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ABSTRACT
Adrenal glucocorticoids are essential for the development of all forms 
of experimental obesity. In the obese {fa/fa) Zucker rats, adrenalectomy 
prevents the further development of obesity, and glucocorticoid replacement 
restores the obese phenotype. We have hypothesized that this dependence 
on glucocorticoids is due to differences in transcriptional regulation of a 
group of genes that are normally regulated by glucocorticoids. We have 
chosen to study the DNA fragments from the upstream region of the malic 
enzyme (ME) gene, which is positively regulated by glucocorticoids. Hepatic 
nuclear extracts from lean and obese Zucker rats were used in band shift 
studies to look for differences in binding of nuclear proteins to the DNA. All of 
the upstream DNA fragments bind more obese nuclear protein than lean 
nuclear protein. Adrenalectomy decreases the amount of obese nuclear 
protein bound to the 222 bp fragment to the sam e level a s  the lean nuclear 
protein. Treatment of the nuclear proteins with alkaline phosphatase altered 
gel retardation patterns and suggests that phosphorylation state  of the 
nuclear proteins is important for DNA binding. The hepatic nuclear extracts 
were also analyzed in 2- dimensional SDS PAGE. Two proteins were 
present in lean nuclear extract but absent from obese nuclear extract. The 
proteins were N-terminal blocked and could not be used for N-terminal 
sequencing. T hese data suggest that changes in nuclear proteins may be 
involved in the altered transcription of this glucocorticoid regulated gene.
Our study suggests that differences between lean and obese Zucker 
rats in nuclear proteins binding to the upstream regions of ME gene may
x
reflect changes in phosphorylation state and differential effects of 
glucocorticoids.
REVIEW OF LITERATURE
Obesity affects more humans than any other health problem. One 
fourth of the United S tates adult population was reported to be more than 
20% above normal weight in 1981 (1). After a decade, more than three in ten 
adult Americans now fall in this category (2), and many of these are grossly 
obese  (3). Indeed, epidemiological studies showed that the prevalence of 
obesity is increasing from generation to generation (4).
Although the mechanisms leading to obesity status are complex and 
diverse, familial studies clearly indicate the influence of genes on metabolic 
regulation (5-7). In an adoption study of human obesity recently performed 
by Stunkard et al. (5) with 540 adult adoptees, a strong relation between the 
weight class of the adoptees and the body-mass index of their biologic 
parents w as observed, w hereas there was no relation between the weight 
class of the adoptees and the body-mass index of their adoptive parents. 
Cumulative distributions of the body-mass index of parents showed similar 
results. This indicates that genetic influences have an important role in 
determining human fatness in adults, w hereas the family environment alone 
has no apparent effect (5). To date, there are  several genes associated 
and/or linked with human obesity (8).
Animal models of genetic obesity
Animal models of genetic obesity, especially single-gene mutation 
obese  animals, are particularly useful for the study of obesity. They can be 
maintained in standard inbred backgrounds, and appropriate matings of the 
animals can give rise to predictable numbers of unaffected and affected
1
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animals, all of which have the sam e genetic background, differing only by the 
presence of a single mutant gene or a small region of the chromosome 
containing the mutant gene (9).
In 1905, genetically determined obesity was first described in the 
yellow m ouse by L. Cuenot (10). Since then, animal models have been used 
to study the metabolic and behavioral changes that lead to obesity. The 
results have been applied to the human obesity caused by single gene 
mutations (8).
More than five m ouse mutations and at least one rat mutation causing 
obesity have been intensively studied and are encoded on five different 
m ouse and rat chromosomes (8). These rodent obesity genes code for 
regions that have human homologous equivalents, which are located on five 
different human chromosomes (Table 1) (11). These animal models cover a 
wide range of changes in the manifestation of obesity coupled with varying 
degrees of diabetes and provide investigators models with which to advance 
our understanding of the causes and development of obesity-diabetes 
conditions (9). To date, three of the mouse genes (a, ob and fat) have been 
cloned (12-14).
The yellow mouse
The agouti locus (a) is located on m ouse chromosome 2. It 
differentially regulates the synthesis of eumelanin (black or brown) and 
phaeomelanin (yellow) pigment granules by the melanocytes within the hair 
follicle (15). Since the original description of the yellow (4y) mouse (10), a 
number of additional alleles have appeared at the agouti locus (12, 16). 
Different combinations of alleles result in an array of different phenotypes,
3







Diabetes (db)* Recessive 4 1p31-pter
O bese (ob)* Recessive 6 7q31
Tubby (tub)* Recessive 7 11 p15.1
Fat (fat)* Recessive 8 16q22-24
Yellow (Ay)* Dominant 2 20q11.2
Zucker (fa)** Recessive 5 1p31-pter
Adapted from references 11 ,15  and 17.
*, from mice. 
**, from rats.
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ranging from subtle changes in coat color from the wild type, to drastic 
changes in the distribution of pigmentation in different regions of the animal, 
especially across the dorso-ventral surface. The lethal yellow (Ay) m ouse has 
an all-yellow phenotype in the heterozygous condition (15, 18), the black-and 
tan (a*) m ouse has an all-black dorsum and an all-yellow ventrum (19), while 
the nonagouti (a) m ouse has a predominantly black phenotype (16) and 
extreme nonagouti (ae) mouse has a completely black phenotype (20). Silver 
and coworkers did a series of experiments to dem onstrate that the a  locus 
functions within the microenvironment of the hair follicle (16, 21-24).
The homozygous dominant yellow mutation causes death in very 
early stages in development, around the time of implantation possibly due to 
a delay in giant cell differentiation, preventing the embryo’s  attachm ent to the 
endometrial cells that line the uterus (25-28).
Pleiotropic effects of the dominant agouti mutations include 
pronounced pbesity (29-32) and increased susceptibility to diabetes (33). 
Heston and coworkers were able to demonstrate that the lethal yellow 
heterozygotes have a tendency to develop a  variety of spontaneous and 
induced neoplasm s including pulmonary tumors, mammary-gland tumors, 
and hepatom as (34-38). In addition, it was reported that the lethal yellow 
heterozygotes exhibit a systemic stimulation in body growth and reduced 
fertility in fem ales (39).
A breakthrough cam e when a radiation-induced inversion mutation 
which contains DNA breakpoints in the limb deformity (Id) and agouti loci 
w as reported in 1990 (40). A DNA probe from the Id region w as used to 
successfully clone a  region of DNA that m aps to the agouti locus (40). Two
5
years later, the agouti gene was cloned and characterized (12). It w as shown 
to encode a 131 amino acid protein. The gene is normally expressed 
predominantly in neonatal skin (12). The dominant yellow (Ay) mutation is 
associated with translocation and overexpression of the gene in most tissues 
of the adult m ouse (12, 18). In 1994, a human homologue of the agouti gene 
was mapped to chromosome 20q11.2 and cloned. The agouti gene and the 
protein that it encodes are now under extensive study. A recent report 
showed that the agouti protein is a  high-affinity antagonist of the melanocyte- 
stimulating hormone (MSH) receptor and blocks a-MSH stimulation of 
adenylyl cyclase, which is the effector through which a-MSH induces 
eumelanin synthesis (41). It was reasoned that the obesity caused by 
ectopic expression of agouti in the lethal yellow (Ay) m ouse may be due to 
the inhibition of melanocortin receptor(s) outside the hair follicle (41).
The obese and diabetes mice
The ob m ouse w as first described by Ingalls et al. in 1950 (42). It 
inherits its obesity a s  an autosomal recessive mutation on chromosome 6 
(43). The earliest detectable change in preobese ob/ob mice is an 
impairment in therm ogenesis (44-45). During the dynamic phase of the 
obesity, hyperinsulinemia and hyperphagia increase with the progressive 
appearance of glucose intolerance, fasting hyperglycemia, and resistance to 
exogenous insulin (46). However the obesity of ob/ob mice is not dependent 
on the hyperphagia (47-49).
The diabetes (dbfdb) mutation on chromosome 4 (43) originally arose 
on the C57BL/KsJ background. It is also an autosomal recessive gene. The 
ob and db mutation cause similar if not identical diabetes-obesity syndrom es
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when maintained in the sam e inbred background (43). The only comparative 
data that distinguish these  two mutations from each other are the results of 
the well-known parabiosis experiments (cross circulation studies) performed 
by Coleman (50-51). In these  experiments capillary anastom oses 
(exchanging 2-3% of cardiac output) were m ade between three se ts of mice. 
In the first se t (ob to wiid-type), it was found that obese mice lost weight, 
indicating that ob is deficient for a  circulation factor that suppresses appetite. 
In the second set (db to wild-type), it was noted that the normal mice starved 
to death while the db mouse survived, suggesting that the db m ouse is 
resistant to a circulating appetite suppressant and it secondarily 
overproduces that factor. The third se t used ob and db mice and it w as found 
that the ob mice starved to death, suggesting that db mice are resistant to 
the sam e factor that is absent or defect in ob mice (11).
With the development of the techniques of positional cloning, the 
m ouse ob gene and its human homologue were recently cloned by J. M. 
Friedman's group (13). First, in 1991, they positioned ob on mouse 
chrom osome 6 and mapped the ob gene between two restriction-fragment 
length polymorphism (RFLP) markers, D6Rck13 and Pax4 (52-54). Then 
they cloned the DNA in the region of Pax4 and D6Rck13, using both probes 
to start the construction of a  physical map in the region of ob (13). Finally, 
using the method of exon trapping, they were able to isolate genes from a 
650-kb interval that was indicated in previous genetic studies to contain the 
ob gene (13, 55). By screening putative exons for the presence of 
corresponding RNA from a variety of tissues using northern blots and 
reverse-transcription PCR, they found 6 genes, one of which, 2G7, was
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hybridized to a  northern blot of m ouse tissues. A 4.5-kb RNA that exists only 
in white adipose tissue was detected and the 2G7 w as used to screen a 
m ouse adipose tissue cDNA library and the isolated clones sequenced (13). 
Their results showed a 167 amino acid open reading frame followed by a 
long 3'-untranslated sequence (13). The predicted amino acid sequence is 
84% identical between human and m ouse and has som e features of a 
secreted protein (13). They suggested that the ob gene product may function 
a s  part of a signaling pathway from adipose tissue that acts to regulate the 
size of the body fat depot. In a severely obese ob/ob mouse line studied by 
Zhang et al., a  nonsense mutation in codon 105 of the m ouse gene has 
occurred and it expresses a 20-fold increase in adipose tissue ob mRNA. 
Another ob mutant mouse strain studied by the sam e group does not show 
any evidence for the expression of the gene (13), indicating the importance 
of the ob product in the maintenance of the non-obese status.
Recently, three articles reported the in vivo studies of the effect of the 
so  called OB protein in mice, which were carried out by three independent 
research groups (56-58). In these  studies, the recombinant m ouse OB 
protein w as expressed in bacterial system s and purified to nearly 
homogeneity. Administration of the OB protein intraperitoneally (56-58), 
intravenously, or intracerebroventricularly (58) all resulted in a  remarkable 
decrease  in the body weight of ob/ob mice compared with that of the lean 
animals. T hese results prove that the OB protein is the "circulating appetite 
suppressant" suggested by Coleman in his parabiosis experiments 
mentioned above (50-51). The most obvious effect of the OB protein is the 
reduction of the animal's appetites. But food intake alone does not seem  to
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account for the overall weight loss induced by the OB protein because the 
OB-treated mice lost 50% more weight than the untreated mice even when 
they were on the sam e diets (57). Pelleymounter et al. were able to show 
that besides the reduction of the animals’ appetites, the OB-treated mice 
increased their total activity to the level of the lean animals and the metabolic 
indices in them were normalized (56). These findings indicate that the OB 
protein also increases the energy expenditure in these animals. Furthermore, 
also consistent with Coleman's parabiosis experiments, the OB protein has 
no effect on dbldb mice, which seem  to have a defect in the receptor for the 
OB protein (57-58). The OB receptor seem s to exist a t least in the brain 
because direct injection of small dose of OB protein into the brains of mice 
resulted in similar effects that were caused by much higher doses when 
given intravenously (58). However, whether the OB receptor may exist 
elsewhere and what exactly happens after the binding of the OB protein to 
its receptor remain to be elucidated.
The fat and tubbv mice
The fat and tub mice were first described by Coleman and Eicher in 
1990 (9), although they were originally found a s  spontaneous mutations at 
The Jackson Laboratory in early 1970's. Breeding tests indicated that these 
obesity conditions were both caused by autosomal recessive mutations. The 
development of obesity syndrome in tubby and fat is slow compared to the 
phenotypically similar ob and db mice. Problems in glucose hom eostasis are 
mild and only transient. Hyperglycemia is only seen  in homozygous fat males 
between the ages of 7-11 weeks w hereas fat fem ales and tubby mutants of 
both sexes remain normoglycemic or slightly hypoglycemic (9). Both of the
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homozygous tub and fat mice are infertile, but not sterile, and can produce 
litters when the animals are mated before severe obesity develops (5-8 
weeks for fat/fat and 12 weeks for tub/tub).
Although mice with a genotype of fat/fat develop obesity at a slower 
rate than homozygous ob or db mice, they still can becom e two (male) or 
three (female) times heavier than wild-type litter m ates (9, 14). Most of the 
excess weight in the fat mutants results from increased weight of body fat 
that distributes to fat stores throughout the body. This is different from the 
pear-shaped body conformation caused by the confinement of body fat to 
the axial and inguinal regions in the ob and db mutants.
The obesity syndromes in the fat/fat rats include increased rate of 
weight gain, high blood sugar concentration, hyperproinsulinemia, and 
abnormal pancreatic morphology. Interestingly, these conditions remain mild 
and diabetes was not present when the fat/fat mutation was placed on the 
BKs inbred background. This is in contrast with the changes from mild to 
severe diabetes observed when either the ob or db mutation was placed on 
the BKs inbred background.
The most striking feature of fat mutants is the pronounced 
hyperinsulinemia (14) which becom es apparent as early a s  4 w eeks of age, 
when obesity is not detectable (9). This symptom w as observed in both the 
BKs background and the HRS/J background, in which the fat mutant was 
originally identified.
In 1994, the fat mutation was mapped to m ouse chromosome 8 by 
Paigen and Coleman (59). In 1995, Naggert et al. were able to link the fat 
gene to the vicinity of carboxypeptidase E (Cpe or Cph-1) by screening for
10
recombinants in progeny of +!fat matings (14). Cpe is an exopeptidase 
involved in the processing of prohormones including proinsulin (60). Naggert 
e t al. showed that the hyperinsulinemia in fatlfat mice is a  consequence of 
abnormal Cpe expression which results in abnormal proinsuiin processing. 
They also demonstrated that the mutant Cpe gene contains a single 
m issense mutation (Ser202Pro), which abolishes CPE enzymatic activity 
when expressed in a baculovirus system. All these  data strongly support that 
fat is a mutation at the Cpe locus. But it is still not known whether that fat 
phenotype is a direct consequence of faulty processing of proinsulin or som e 
other hormone because fat mice are not always hyperglycemic. Since the 
expression of Cpe is not limited to pancreatic islets, Naggert et al. proposed 
that the development of obesity may be a more direct consequence of 
abnormal processing of som e other neuroendocrine prohormone (e.g. 
neuropeptide V, enkephalins, proopiomelanocortin and oxytocin- 
vasopressin), and not simply insulin (14). The fact that the fatlfat mice are 
functionally infertile also supports the suggestion that there are defects in the 
neuroendocrine axis.
Tubby mice are phenotypically very similar to fat mice except for 
slower development of obesity (The phenotype cannot be recognized until 9- 
12 weeks of age) and the existence of sexual dimorphisms with respect to 
rate of weight gain, plasma insulin concentration, and pancreatic morphology 
in tub mice. The average weight at 24 weeks is 46.4±0.9 g in tub/tub males 
compared to only 38.6±1.1 g in females. Both sexes develop mild 
hyperglycemia associated with hyperinsulinemia. Histological examination of 
the pancreas showed relatively normal islet morphology in both sexes when
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compared to normal littermates. Some enlargement of the islets occurred at 
12 weeks of age in males and 24 weeks in females. Degranulation of the p 
cells w as seen  only in the late stages, indicating that insulin synthesis and 
secretion in tub/tub mice can be sustained at levels sufficient to maintain 
near normal p-cell granulation (9). The tub gene has been located on 
chrom osome 7 near the Hbb (hemoglobin beta-chain complex) locus and 
related studies are  still underway.
The Zucker rats
The obese Zucker {fa/fa) rat was first described in 1961 as a 
spontaneous mutation in a cross between the Merck Stock M and Sherm an 
rats (61). The obese phenotype is transmitted as an autosomal recessive 
trait and the homozygous animals suffer the consequences of genetic 
obesity, which closely resem bles human juvenile onset obesity (62-64).
Zucker fatty rats eat large meals compared with the food intake of 
their lean litter-mates (47-55, 65-69). However hyperphagia is not the only 
responsible factor because pair-feeding obese rats with lean ones does not 
prevent the development of the obesity (69-70) and food restriction before 
weaning failed to stop the hypertrophy and hyperplasia of adipose tissue 
depots (71).
The concentration of both circulating cholesterol and triglycerides in 
the obese  Zucker rats is very high (61, 69, 72). This hyperlipidemia is 
characterized by increases in all lipoprotein c lasses with marked elevations 
in very low density lipoproteins (VLDL) (73). The pathogenesis of the 
hyperlipidemia in obese Zucker rats is not completely understood. It was 
suggested that increased production of lipoproteins is the major cause (74).
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In the liver of obese Zucker rats there is an increase in lipogenesis with a 
concomitant decrease in fatty acid oxidation (75-76). The activity of 
lipoprotein lipase, which hydrolyzes plasma triglycerides, is elevated in white 
adipose tissue and reduced in brown adipose and muscle a s  early a s  the 
first or second week of life (77-78).
Hypertrophy and hyperplasia of the p-cells in obese Zucker rats 
results in a major hypersecretion of insulin. The insulin levels in obese 
Zucker rats are above those of the lean rats a s  early a s  3 weeks of age (65, 
79). Fasting insulin levels were increased by 10-fold in fa/fa rats compared 
with lean Zucker rats (80). Postprandial insuHn levels were even higher in 
obese Zucker rats (69). Despite this increase in plasma insulin levels, obese 
Zucker rats had higher plasma glucose levels than lean Zucker rats (80).
This is because obese Zucker rats also develop insulin resistance, which has 
been well documented (69, 74, 80-83). The life span of obese Zucker rats 
can be divided into two stages based on insulin resistance. In the first stage, 
there is a  pancreatic oversecretion of insulin with a reduced hepatic 
clearance of the hormone (84), while a general state of insulin resistance is 
present in the later stage (69). Both in vitro and in vivo experiments have 
demonstrated the insulin status in obese Zucker rats. Decreased insulin 
binding to plasma mem branes has been observed in isolated liver, muscle 
and adipose cells (69), and it has been shown that hepatic glucose 
production in obese Zucker rats was not inhibited by insulin, indicating that 
gluconeogenesis and lipogenesis are insulin resistant in liver (69). Insulin 
resistance was initially thought to be caused by decreased insulin binding 
because of the observation of decreased insulin receptor numbers in the
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obese  Zucker rats (85). It w as later realized that this decreased binding was 
not sufficient to explain the overall state of resistance because it has been 
shown that food intake restriction or pair-feeding can restore the levels of 
insulin to normal in adult rats (76). It w as reported that insulin-stimulated 
protein kinase activity, a  postreceptor event, w as decreased in both heart 
and liver tissue from obese Zucker rats (86). These studies suggest that 
insulin resistance in obese Zucker rats involves both receptor and 
postreceptor abnormalities a s  will be discussed later.
The thermogenic capacity of brown adipose tissue is significantly 
reduced in obese mice or rats when compared with that in lean ones 
although the obese ones exhibit increased brown fat m ass (87-88). It has 
been shown that the brown fat metabolism of the obese Zucker rats does not 
increase as much in response to maximum doses of the beta agonist 
isoproterenol a s  in the lean rats (89) and the maximum activities of several 
brown fat oxidative enzym es are lower in obese Zucker rats (78).
G. E. Truett and coworkers mapped fa between two molecular 
markers, Ifa and Glut-1, which also flank db on mouse chromosome 4 and 
are located on rat chromosome 5. Their results placed fa on rat chromosome 
5 and suggested that db and fa are mutations in homologous genes (90). 
Both the fa and db gene appear to have a human counterpart on 
chromosome 1p31 (29).
In the experiments carried out in 1981 by R. B. S. Harris using tube- 
feeding induced obese rats (91), the obese rats appeared to produce a 
blood-borne factor that has a very mild effect on food intake and caused the 
selective depletion of body fat, indicating that this factor is probably anti-
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lipogenic. The parabiosis experiments between falfa and wild-type rats 
performed later by the sam e group (66) showed that the fatty rat exerts the 
sam e effect as do db mice. Interestingly, it has been shown that ventral 
medial hypothalamus (VMH) lesioned rats also behave similarly to db mice 
and fa rats in parabiosis experiments (67). All these results indicate that the 
blood-borne factor in rats is very likely the rat homologue of m ouse ob gene 
product and this factor is not functioning properly in these  falfa rats. Not 
surprisingly, it was recently found that the ob mRNA level in fa/fa rats was 10 
fold higher than in their lean litter m ates (Abstract in press, X. Lin and D. A. 
York).
Glucocorticoids and obesity
Since the first description and isolation of glucocorticoid hormones 
more than half a century ago (92), their roles in development, metabolism 
and the response to stress have been intensively studied.
Glucocorticoids are secreted from the zona fasciculata of the adrenal 
cortex after being synthesized from cholesterol by a series of reactions (93). 
The major glucocorticoid in man is cortisol and in rat, corticosterone. About 
95% of the glucocorticoids in the circulation are bound to plasma proteins, 
primarily corticosteroid-binding globulin. The secretion of glucocorticoids is 
regulated by adrenocorticotropic hormone (ACTH, corticotropin). ACTH is 
produced by the pituitary gland and is regulated by corticotropin releasing 
factor (CRF), which is in turn produced by the hypothalamus. By feedback 
regulation, the glucocorticoids inhibit ACTH production and secretion, 
probably at both the hypothalamic and pituitary levels (94). B ecause the 
glucocorticoids are lipid-soluble, they readily cross the plasma m em brane
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and combine with the glucocorticoid receptor, the first steroid receptor 
discovered (95).
As signals to cope with stress, glucocorticoids have effects on a  wide 
range of tissues and metabolic pathways, involving stimulation of many 
physiologic, metabolic, cardiovascular, and other functions (93). The 
metabolic effects of glucocorticoids lead to the propensity of hyperglycemia 
and nitrogen wasting. In the liver, the glucocorticoids increase glucose 
production because of the induction of gluconeogenic enzymes, permissive 
effects on the actions of glucagon and epinephrine, and increased 
availability of substrate. Glucocorticoids induce breakdown of both protein 
and nucleic acid and inhibit protein synthesis in muscle, making muscle the 
major source of amino acids. In adipose tissue the glucocorticoids stimulate 
lipolysis, promote the lipolytic effect of epinephrine, and increase the 
production of lactic acid. Glucocorticoids and insulin generally have 
antagonistic effects w hereas the actions of a  number of other hormones may 
be amplified by glucocorticoids. It has been suggested that glucocorticoids 
may be required by the adrenal medulla to produce epinephrine, which has p 
-adrenergic activity (93).
Glucocorticoids have an important function in regulating body weight 
(93). Both acute and chronic administration of corticosterone can induce 
obesity in normal mice (92). The cause for this response is probably 
increased food consumption, and circulating insulin a s  well a s  the decrease 
of therm ogenesis in brown adipose tissue (96-98).
Circulating glucocorticoid levels are increased in the obtob and dbldb 
mice (99-100). However most studies have found normal levels of
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corticosterone in the obese  Zucker (fatty) rat (65, 101-105), although som e 
studies have shown marginally increased circulating levels of corticosterone 
(101-102). Studies in rats with VMH lesions also showed normal 
corticosterone concentration (27). These results indicate, a s will be 
discussed below, that there is an increased responsiveness to 
glucocorticoids in the experimental animal obesities (46, 106).
The development of all the experimental obesity models can be 
prevented or suppressed by adrenalectomy and restored by replacem ents of 
glucocorticoids (46). It occurs in hypothalamic obesity after VMH and PVN 
lesions (107), in dietary obesity after feeding high fat diets to certain strains 
of rat (108), in older rats that become obese on "cafeteria" diets (109) and in 
the genetic obese animals such as obfob (98, 110-113), dbldb (114), and 
Ay/a (115) mice and falfa rat (116-120).
An increased sensitivity and responsiveness to glucocorticoids 
appears to be characteristic of the experimental animal obesities (46, 106). 
This altered responsiveness and sensitivity were widely observed in the 
studies with replacement doses of glucocorticoids given to adrenalectomized 
lean and obese animals (110, 119 ,121-122).
Most of the abnormalities that are associated with the development of 
obesity in animal models, especially those that are involved in carbohydrate 
and protein metabolism, have been shown to be influenced by the 
restorative effects of adrenalectomy. These abnormalities include body 
weight (88,123), fat deposition (124), fat cell size (120), muscle weight 
(111), energetic efficiency (88,123-124), food intake (88,125), meal pattern
(125), thyroid function (112), islet cell distribution (114), insulin concentration
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(115, 124), insulin response (113), glucose tolerance (96), protein synthesis
(126), lipoprotein lipase (115), lipogenesis (117), brown adipose tissue 
function (127), body temperature (128), mRNA level of malic enzyme and 
GAPDH (118), etc. Although the falfa rat may have marginally increased 
circulating levels of corticosterone (101-102) this cannot account for the 
glucocorticoid dependence since replacement of adrenalectomized obese 
rats with glucocorticoids will restore obesity w hereas identical treatment of 
adrenalectomized lean rats has no such effect.
Although adrenalectomy has a wide-ranging restorative effects a s 
mentioned above, it does not restore body composition and serum insulin 
levels precisely to those seen  in lean rats because som e of the changes are 
already irreversible. This is well demonstrated by observation of serum 
insulin. The serum insulin falls to low levels after adrenalectomy (112) but 
still remains slightly elevated when compared to the lean animals. This has 
been reasoned to result from the existing hyperplasia and hypertrophy of the 
islet tissue because serum insulin levels of the w eaned fa/fa rat have been 
found to stay at the lean levels if the adrenalectomy is performed prior to 
weaning (117). The reduction of serum insulin level in the obese animals 
after adrenalectomy probably results from a decreased activity of the 
parasympathetic nervous system and the enteroinsular axis and an 
increased activity of the sympathetic nervous system that links to the 
pancreas (117). Therefore it seem s that adrenalectomy normalizes 
autonomic balance, islet anatomy (114), and glucose metabolism (96, 129).
In a study performed by Langley and York (130), young obese falfa 
rats were treated with RU-38486, a type II glucocorticoid receptor antagonist,
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for 15 days. Analysis of body composition changes showed that RU-38486 
effectively reversed the obesity. It stopped fat deposition in obese rats but 
increased protein deposition to the level of lean-vehicle rats. RU-38486 also 
prevented the development of hyperphagia and reduced gross energetic 
efficiency in the obese rats but had little effect on lean rats. The study also 
showed that mitochondrial GDP binding was increased in brown adipose 
tissue of obese rats but w as reduced in lean rats by RU-38486 treatment. 
RU-38486 also reduced the elevated activity of hippocampal 
glycerophosphate dehydrogenase, a glucocorticoid-responsive enzyme, of 
obese  rats to the level of lean rats. Their results suggested that abnormal 
activity of glucocorticoid receptors or abnormal cellular responsiveness to 
corticosterone receptor complexes may be important in the development of 
obesity in the falfa rat.
A transgenic m ouse with impaired corticosteroid receptor function was 
created by partially knocking out gene expression with type II Glucocorticoid 
receptor (5q31-32) antisense RNA (131). The transgenic animals had 
increased fat deposition and a body m ass that by about 6 months of age was 
twice a s  large a s  that of controls. An elevated body fat content w as observed 
despite the fact that transgenic animals ate about 15% less than the normal 
mice. Increased serum concentrations of corticosterone and ACTH, a similar 
feature seen  in obese fa/fa rats, were also seen  in these animals. These 
results clearly indicated the important role that glucocorticoids play in the 
development of obesity. However, they argue against all other experimental 
data, which showed the positive effect of the glucocorticoid receptor in the 
development of obesity, although the mechanism is still unknown.
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Insulin and the development of obesity
Discovered over 70 years ago, insulin is the most important secretory 
product of the pancreatic beta cell and plays a  central role in the regulation 
of many key metabolic processes (132). Hyperinsulinism, insulin resistance, 
and decreased number of insulin receptors are characteristic of obesity in 
both human and experimental animals (133). As has been mentioned above, 
fasting insulin levels were increased by as much a s  10-fold in obese  Zucker 
rats compared with lean Zucker rats (80). Postprandial insulin levels were 
even higher in obese Zucker rats.
In contrast to glucocorticoids, which are steroid hormones, insulin is a 
polypeptide hormone (134) produced by the p-cells of the pancreas in 
response to nutritional, neural and endocrine stimuli. The most important 
physiological regulator of insulin release is glucose (135). Amino acids, 
especially the essential amino acids leucine, arginine, and lysine, have been 
shown to stimulate insulin release in the absence of glucose (136). However, 
various lipids and their metabolites appear to have only minor effects on 
insulin release (137). The pancreatic hormone glucagon has a stimulatory 
effect on insulin release (138), while somatostatin inhibits insulin release 
(139). Other hormones, such a s  glucocorticoids, prolactin, growth hormone, 
placental lactogen, and the sex hormones, have also been found to stimulate 
insulin secretion (140). It was reported that the adrenergic neurotransmitters, 
norepinephrine and epinephrine, suppress insulin release and 
parasympathomimetic agents stimulate insulin release (141). In vivo studies 
of beta-cell secretory function have demonstrated that insulin is released in a 
pulsatile m anner (142).
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The major site of insulin metabolism is liver (143), which extracts half 
of the insulin delivered to it. The first step in degradation of the hormone 
appears to be binding to receptors on the hepatocyte surface. After insulin is 
internalized, at least som e of them has been shown to serve as the substrate 
for degradation (143). Other sites of insulin metabolism include kidney, 
adipose tissue, blood cells, and placenta (144).
Although insulin exerts regulatory or growth effects on almost every 
cell of the body, the most important tissues for insulin action are muscle, 
liver, and adipose tissue (132). Insulin activates the transport system s and 
enzym es involved in utilization and storage of glucose, amino acids, and 
fatty acids, and inhibits gluconeogenesis, glycogenolysis, lipolysis, and 
protein breakdown (145).
Insulin released into blood binds to the a subunit of its receptor in its 
target tissues and activates the receptor tyrosine kinase. This, in turn, 
initiates the cellular processes that regulate organismal glucose hom eostasis 
by activation of existing transport systems, recruitment of intracellular 
proteins such a s  glucose transporters (GLUT-4) from intracellular storage 
vesicles to the plasma membrane (146-147), and covalent modification of 
pre-existing enzym es by phosphorylation or dephosphorylation such as 
pyruvate dehydrogenase, acetyl-CoA carboxylase, triacylglycerol lipase, 
phosphorylase kinase, and glycogen synthase and phosphorylase (148). On 
a slightly slower time frame (i.e., several minutes to a few hours) than for 
nutrient transport, insulin also regulates transcription of specific genes and 
new protein synthesis. It has been known that insulin stimulates the 
synthesis of pyruvate kinase, malic enzyme, and glucokinase and inhibits
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that of phosphoenolpyruvate carboxy kinase (PEPCK), carbamoyl 
phosphate synthetase I, and fructose-1,6-bisphosphatase (145, 149). 
P hosphory la tion  of the  g lucocorticoid  recep to r and  insulin recep to r
Although the discovery of protein phosphorylation as a mechanism by 
which extracellular signals regulate cellular functions w as dated a s  early as 
the late 1950s (150), it has been only a  few years since protein 
phosphorylation/dephosphorylation began to be recognized a s  a critical 
mechanism in signal transduction used by numerous growth factors and 
hormones, including glucocorticoids and insulin (151-152). The 
phosphorylation of nuclear proteins has been widely observed in the 
regulation of gene transcription (153). The C-terminal domain (CTD) of the 
large subunit of RNA polymerase II has multiple repeats that can be 
phosphorylated at multiple sites (154). It has been shown that the 
hyperphosphorylated form is the major form in transcribing polymerase II 
complexes (155) and that only the un-phosphorylated form of polymerase II 
can enter the initiation pathway. It was proposed that phosphorylation of this 
subunit may be needed to trigger conversion of an initiation complex into an 
elongation complex (156) although the true nature of the CTD protein kinase 
is unknown. Pulverer et al. were able to demonstrate that the DNA binding of 
c-Jun is negatively regulated at one se t of sites by phosphorylation and 
phosphorylation at another set of sites increases transactivation activity 
(157). Phosphorylation is also reported to be able to modulate nuclear 
translocation and other properties of transcription factors such a s  the 
interaction between factors when bound to neighboring sites in a promoter or 
enhancer (158). However, the identification of transcription factors which
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direct gene transcription a s  a result of posttranslational modification has 
been difficult to demonstrate.
There have been reports of changes in the activity of a protein 
phosphatase (glycogen synthase phosphatase) (159-160) in hepatocytes 
from obese Zucker rats. Furthermore, M. D. Houslay’s  studies showed that 
ligands which enhanced Gr 2 phosphorylation in intact hepatocytes from lean 
Zucker rats failed to do so in hepatocytes from obese  animals. They 
suggested that this defect in guanine-nucleotide-mediated “G| function” seen  
in obese Zucker rats may be due to an inactivating phosphorylation of aG r 2 
(161).
Glucocorticoid receptor
Like other steroid receptors, the glucocorticoid receptor consists of a 
ligand binding domain, a DNA binding domain, and a poorly conserved N- 
terminal region which is considered to be a transcriptional modulation 
domain (162-163).
In the absence of the glucocorticoid hormone, a  monomer of the 
glucocorticoid receptor, two molecules of heat shock protein (HSP90), and 
several other heat shock proteins interact with each other and form an 
aporeceptor complex (164). The complex is in dynamic equilibrium with two 
unliganded, non-HSP90-bound receptor forms, namely an unliganded 
inactive receptor that can neither bind to DNA nor enhance transcription and 
an unliganded "active" receptor that can bind to DNA and enhance 
transcription (165). Hormone binding leads to activation of the receptor and 
dissociation of HSP90 (166), which is a  substrate-specific chaperone (68, 
164).
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Proper interaction of the glucocorticoid receptor with HSP90 is 
essential for efficient ligand binding and response (167-169). It was recently 
suggested that steroid receptors, including glucocorticoid receptors, may 
require heat shock protein 70 (HSP70, or DnaK) (168) and DnaJ like proteins 
(170-171), both molecular chaperones, for assembly and maintenance of the 
aporeceptor in the absence of ligand and for proper folding of the activated 
receptor after ligand binding (165).
Upon binding of the glucocorticoid to the receptor, the activated 
receptor-hormone complex then translocates from the cytoplasm to the 
nucleus, probably with the help of certain proteins that promote nuclear 
import (172). The receptor-hormone complex binds to specific glucocorticoid 
response element (GRE) (173-175) on the DNA of target genes which allows 
binding of transcription factors and RNA polymerase to initiate or inhibit 
transcription. The DNA binding domain of the receptor consists of 2 cysteine 
"zinc fingers" which interact with specific bases in the GRE (173). GR will 
only fully regulate gene transcription when it binds to the GRE in the form of 
a dimer (176).
Glucocorticoid receptor is basally phosphorylated and undergoes 
hyperphosphorylation after hormone-induced activation (177). In the mouse 
glucocorticoid receptor, seven phosphorylation sites have been identified by 
Bodwell et al. in 1991 (178). Single mutations at all seven sites and 
combinations of substitutions displayed levels of hormone-induced reporter 
gene expression that are similar to wild type receptors (179). Thus it seem s 
that phosphorylation of the GR at the seven identified sites is not a  major 
determinant in GR mediated transcription activation. Therefore
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phosphorylation of various components of the GR signal transduction 
pathway, and not necessarily the receptor itself, may influence its 
transcriptional regulation activities (180).
Phosphorylation can increase the negative charge and acidity of one 
or more regions of a  protein, influencing its interactions with other proteins or 
with DNA. Thus hyper- and hypophosphorylation a t the sam e time in 
different regions or at different time in the sam e region of steroid receptor 
molecules might serve as a  mechanism for differential transcription 
regulation of certain genes (181). Furthermore, the fact that there are so 
many phosphorylation sites affected by different kinases/phosphatases and 
signal transduction pathways suggests that phosphorylation is involved in 
the regulation of multiple receptor functions (181).
Insulin receptor
The insulin receptor is located on the surface of most mammalian 
cells, including both the classic insulin target tissues (liver, muscle, and 
adipose tissue) and nonclassic target tissues (blood cells, brain, etc.). The 
number of insulin receptors ranges from less than 100 per cell to more than 
200,000 per cell, the higher concentrations primarily being on adipocytes 
and hepatocytes. Any insulin analogue that binds to the receptor exerts a 
biological effect in proportion to its affinity for the receptor. The insulin 
receptor is a  transm em brane glycoprotein with a molecular weight of 
approximately 350 to 440 kDa. The receptor is a  heterotetramer composed 
of two a-subunits (135 kDa) and two p-subunits (95 kDa) linked by disulfide 
bonds (182-183). The a  subunits are  located entirely outside the cell. The 
two subunits are  covalently linked to each other by disulfide bonds. There
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are 735 amino acids in the a  subunits which contain the insulin binding sites. 
The p subunits are transm em brane proteins and are composed of a 193 
amino acid extracellular domain, a  23 amino acid alpha-helical 
transm em brane domain, and a 402 amino acid intracellular domain that 
p o ssesse s  an insulin-regulated tyrosine protein kinase activity (182-183).
In 1981, Kasuga et al. first reported that the insulin receptor contains 
a  tyrosine kinase activity (184). This finding w as later confirmed by cDNA 
cloning, which revealed that the insulin receptor belongs to the family of 
tyrosine kinase receptor family (185). The receptor tyrosine kinases have 
been divided into three groups (186): the epidermal growth factor (EGF) 
receptor family which are monomeric with two clusters of cysteine-rich 
regions in the extracellular domain and the major autophosphorylation sites 
in the C terminus (187), the platelet-derived growth factor/colony-stimulating 
factor 1 (PDGF/CSF-1) receptor family which have an immunoglobulin-like 
distribution of cysteine residues in the external domain and a stretch of -100  
amino acids which interrupts the intracellular kinase domain (188), and the 
insulin receptor family which has a  single cluster of cysteine residues in the 
extracellular a  subunits and a kinase domain in the p subunits that 
resem bles the kinase domain of the prototype tyrosine kinase (189).
The tyrosine kinase activity of the insulin receptor is essential for all 
known early and late cellular responses evoked by insulin (190). In the 
unoccupied state, the tyrosine kinase activity intrinsic to the p subunit of the 
insulin receptor is inhibited by the a  subunit. This inhibition can be released 
by insulin binding or removal of the a  subunits using proteolytic enzym es 
(191). it has been shown that insulin binding induces a  propagated
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conformational change through the transm em brane domain in the p subunit 
of the receptor (192-193).
The most critical intracellular portion of the insulin receptor p subunit 
required for normal receptor function is the consensus amino acid sequence 
encoding an ATP binding domain marked by a distinctive glycine-rich motif 
(Gly-X-Gly-X-X-Gly) followed by a  lysine residue 12 amino acids 
downstream. This lysine residue is absolutely required for insulin action 
since substitution with any other amino acid invariably blocks 
autophosphorylation and kinase activity and all biological responses (194).
There are a total of seven phosphorylation sites in the intracellular 
domain of the p subunit. Activation of the insulin receptor by insulin binding 
leads to the autophosphorylation of the three tyrosines in the regulatory 
region in the intracellular domain of the p subunit (195). This, in turn, results 
in a greatly increased kinase activity (196). Using mutation analysis, Sun et 
al. were able to show that another autophosphorylated tyrosine residue 
residing in the juxtamembrane region of the receptor is important for the 
phosphorylation of endogenous receptor substrates (197). Furthermore, the 
insulin receptor is under regulation by serine and threonine phosphorylation 
(184).
In 1985, White et al., using antiphosphotyrosine antibodies that 
recognize proteins based on the presence of the phosphotyrosine side chain 
independent of the primary sequence of the protein and 32P-labeled 
hepatom a cells, identified the major intracellular substrate of the insulin 
receptor, IRS-1 (originally named pp185) (198). Phosphorylation of IRS-1 
w as found to reach to its maximal level within seconds after the cells were
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exposed to insulin. The dose-response curve was similar to that of receptor 
autophosphorylation, suggesting that it represents the endogenous substrate 
for the insulin receptor kinase. Subsequently, IRS-1 has been found in most 
cell types. The amino acid sequences of IRS-1 are 98% homologous 
between human and mouse, and 90% homologous between human and rat.
IRS-1 has approximately 35 to 50 potential Ser/Thr phosphorylation 
sites. It is strongly serine-phosphorylated even in the basal state. The 
phosphorylation level is further increased after insulin stimulation (199). IRS- 
1 also contains 14 potential tyrosine phosphorylation sites, six in Tyr-Met X- 
Met motifs and three in Tyr-X-X-Met motifs (197). The fact that these  sites 
are identical in rat, mouse, and humans suggests that they have important 
functions (200). It has been shown that, following autophosphorylation of the 
tyrosine residues, a  number of cellular enzym es involved in signal 
transmission could bind reversibly to Tyr-Met X-Met or Tyr-X-X-Met sites in 
som e oncogene products, and PDGF and EGF receptors (200). The proteins 
that bind to these  phosphorylation motifs have been found to contain special 
recognition domains termed SH2 (src homology 2) domains (201), which are 
structural elem ents in many proteins that bind with high affinity to 
phosphotyrosine residues in activated tyrosine kinases and participate in 
cellular signaling (200). SH2 domains have been found in som e oncogene 
products (such as src, abl, and related tyrosine kinases) (202), som e 
structural proteins, several enzym es (including the phosphatidylinositol 3 - 
kinase, the phospholipase Cy, and the GTPase-activating protein of ras) 
(203), and a recently discovered class of adapter proteins represented by 
the protein Grb-2 (204).
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Phosphorylated IRS-1 has been demonstrated to bind strongly to 
phosphatidylinositol 3'-kinase (PI-3-Kinase) (197), which phosphorylates the 
lipid phosphatidylinositol. This binding has been shown to be between the 
tyrosine-phosphorylated Tyr-Met-X-Met motifs of IRS-1 and the SH2 
domains in the p85 subunit of the PI-3-Kinase (205). Therefore it has been 
speculated that IRS-1 might function as a mediator in insulin signal 
transmission by binding to certain SH2 domain-containing proteins during 
insulin stimulation and regulating the associated catalytic activities that 
m ediate the insulin response (190). It has also been suggested that the PI-3- 
Kinase is involved in the insulin-induced glucose transporter translocation in 
adipocytes and skeletal muscle (206)
By a mechanism not yet clear, the initial tyrosine cascade of insulin 
action triggers a  series of serine and threonine phosphorylation and 
dephosphorylation reactions (190). Insulin stimulation leads to the activation 
of a variety of serine protein kinases, including the MAP kinases, Raf-1 
kinase, acetyl-CoA carboxylase kinase, ATP-citrate lyase kinase, casein 
kinase II, and the ribosomal S6 kinases (207).
Recent reports have linked insulin receptor signaling to the Ras 
activation pathway (208-209). The observations that ras mutation or 
antibodies against ras abolished insulin action clearly indicated that ras is an 
integral component of certain insulin signaling pathways (210-211). It has 
been shown that all ras-related proteins bind guanine nucleotides (GTP and 
GDP) and possess intrinsic GTPase activity (212). The ras protein has been 
suggested to serve a s  a biological switch that is "on" when GTP is bound 
and "off' when the GTP is hydrolyzed to GDP (213). The GTPase activity of
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ras is regulated by two accessory proteins, guanine nucleotide-releasing 
protein (GNRP) which catalyzes the dissociation of GDP from ras, and 
GTPase-activating protein (GAP) which catalyzes hydrolysis of GTP to 
control the GTP/GDP ratio. A recently cloned molecule Grb-2, which 
contains one SH2 domain and two SH3 domains, has been suggested to 
serve a s  an adaptor in the signal pathway between the EGF receptor and 
ras (209). The activation of Ras requires autophosphorylated receptors such 
as PDGF, EGF, and IRS1. The Grb-2 binds to the IRS-1 and to a GNRP 
called m Sos (mammalian son of sevenless), linking insulin action to the ras 
pathway (208-209, 214-218).
The key component of the Ras pathway is the so  called mitogen- 
activated protein kinases (MAP kinases), or extracellular signal regulated 
kinases (ERKs), which were first described by Ray and Sturgill in 1987 (219). 
The Ras pathway activated by tyrosine phosphorylation (220) leads to 
activation of c-Raf, the serine/threonine protein kinase and protooncogene 
product, which in turn activates additional serine/threonine kinases including 
MAP kinase kinase/ERK kinase (MEK) (221). The activation of MAP kinase 
kinase leads to the activation of serine/threonine kinases or "switch kinases" 
such a s  the MAP-kinases in a cascade  of kinase activity leading to 
alterations in gene transcription and other cellular changes (153, 222). The 
MAP-kinase cascade is triggered not only by several tyrosine kinase 
receptors, but also by G protein coupled receptors (190).
The substrates for the MAP-kinases include cytoplasmic enzym es 
such as p90rek (the 90 kDa form of ribosomal protein S6 kinase), MAPKAP-
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kinase 2 (MAP kinase-activated protein kinase 2), and phospholipase A2 
and a  series of transcription factors such a s  c-Jun, c-Myc, and c-Myb (207). 
In order to elucidate the signal transduction pathway of insulin action on 
gene expression, beginning in late 1980's, researchers have been 
attempting to define cis-acting sequences that mediate the effect of insulin 
on gene transcription and work backward to define the mechanisms by which 
the trans-acting factors that interact with these sequences are  regulated 
(223-225).
With the help of mutation analysis of a  number of insulin responsive 
genes and functional analysis in several transfection systems, insulin- 
responsive elem ents (IREs) have been delineated in the 5' flanking region of 
several genes including those for phosphoenolpyruvate carboxykinase 
(PEPCK), c-fos, amylase, pyruvate kinase, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), glucagon, insulin-like growth factor binding 
protein-1 (IGFBP-1) and malic enzyme (223-230). However, to date, none of 
the proteins that bind to these IREs have been characterized and none of 
the known transcription factors has been found to bind to the IREs (190).
A distinctive feature of the IREs is the lack of a  consensus sequence and 
both positive IREs and negative IREs exist. The IREs of the PEPCK gene 
and IGFBP-1 gene mediate negative regulation by insulin (225, 229, 231), 
the IRE of the amylase gene mediates positive regulation by insulin (226), 
while there are  two IREs on the malic enzyme gene, one positive, the other 
negative (230). One or more proteins have been shown to be able to bind to 
the above mentioned IREs (225-227, 229) during gel shift assays. None of 
the proteins responsible for the different bands formed in these  gel shift
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assay s has been characterized. Nevertheless insulin has been shown to 
increase the amount of protein that binds to the IREs for growth hormone 
and GAPDH. This increase apparently resulted from a  phosphorylation event 
that increases the affinity of the protein for its IRE (224, 232-233). Therefore, 
phosphorylation/dephosphorylation of transcription factors may serve a s  a 
common mechanism by which insulin regulates the transcription of a variety 
of genes.
Malic enzyme and its gene
Malic enzyme (ME; EC 1.1.1.40), the activity of which was originally 
identified in pigeon liver extracts by Ochoa et al. (234), catalyzes the NADP- 
dependent oxidative decarboxylation of malate (235):
Malate + NADP+ -► pyruvate + C 0 2 + NADPH
The pyruvate formed in this reaction readily diffuses into mitochondria, 
where it is carboxylated to oxaloacetate by pyruvate carboxylase. The 
NADPH provides reducing power required for fatty acid synthesis.
ME is a tetram er of four structurally identical subunits and is widely 
distributed (236). It has been grouped with other enzym es which are 
important in lipogenesis, including the hexose-m onophosphate shunt 
dehydrogenases, ATP-citrate lyase, and fatty-acid synthetase. The level of 
ME strongly correlates with fatty acid synthesis and is regulated by complex 
hormonal (237-239) and dietary (240-243) interactions. The ME gene is 
transcribed into two mRNAs of 3.1 kilobase (kb) and 2.1 kb, respectively. 
Although both mRNAs can be effectively translated into the functional 
protein, they are differentially expressed in a  tissue-specific manner; in liver, 
the 2.1 kb form is preferentially expressed while the other form is expressed
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in other mammalian tissues. However, there is no evidence up to now for a 
selective transcriptional regulation, and it has been suggested that different 
tissue-specific polyadenylation factors are involved (244).
Bray and York (118) reported that the levels of mRNA for ME and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were increased in 
liver and adipose tissue of young obese fa/fa rats. Hepatic ME and GAPDH 
mRNA w as reduced by adrenalectomy of fa/fa rats and showed a dose and 
time dependent increase after corticosterone replacement, while 
glucocorticoid replacement had much smaller effects on ME and GAPDH 
mRNA in lean rats.
The coding nucleotide sequence of rat hepatic ME mRNA as well as  a 
882 base  pair (bp) 5-flanking region of the ME gene have been cloned and 
sequenced by V. M. Nikodem's group in late 1980’s. Consistent with the 
enzym e's wide tissue distribution, the structural organization of the ME 
promoter resem bles promoter regions of several eukaryotic constitutive or 
"housekeeping" genes (245).
Deletion analyses of the ME gene promoter region showed that 
sequences +1 to -41 are sufficient to initiate expression (245). Inclusion of 
information up to -177 is necessary for maximal promoter activity. Further 
upstream  region (up to -882) contains the binding sites for many nuclear 
proteins and transcription factors (Table 2, Figure 1), such as thyroid 
hormone receptor (TRE), insulin related proteins (IRE), Jun, Fos (AP-1),
Sp1, HNF3a, and glucocorticoid receptor (GRE). A TATA box (245, usually 
located 20 to 30 bp upstream from cap sites, lies at -626 to -621 (Figure 1).
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Table 2. Protein binding sites on ME gene upstream region
Binding sites Positions Sequence References
IRE-1 -693 to -687 TGT'I ITG 230
HNF3a binding site -696 to -687 TATTGTTTTG 246
TATA -626 to -621 TATAAA 245
GRE -501 to -487 CAGGAAAATTGTTCT 247
TRE -281 to -266 TTGGGGTTAGGGGAGG 248
IRE-II -162 t o -169 CCCGCCC 230
Sp1 -177 to -168 GCCCCGCCCC 249
AP-1 -132 t o -126 TGACTCA 249
Figure 1. The map of the upstream region of ME gene. The 925 bp upstream 
region of the ME gene is shown (open bar). Sites used to generate the DNA 
fragments to be used in the band shift assays are indicated above the open 
bar with their positions. DNA fragments are shown as either shaded or 
hatched bars below the open bar and their sizes indicated below each 
fragment. Sequences that bind nuclear proteins are shown a s  solid boxes in 
the open bar. Restriction sites mentioned in the text are also indicated above 
the open bar.
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Therefore it is of interest to investigate the binding of the hepatic 
nuclear proteins from obese and lean Zucker rats to this region of the ME 
gene in order to gain knowledge about the mechanism of the involvement of 
glucocorticoids and insulin in the development of obesity.
Objectives
In order to further our understanding of the m echanisms that lead to 
obesity, and to verify the hypothesis that the increased glucocorticoid 
responsiveness in obese animals is caused by altered transcription factors, 
this dissertation research was undertaken to examine the binding of hepatic 
nuclear proteins from obese and lean Zucker rats to glucocorticoid regulated 
genes such a s  ME. The initial study on the SDS PAGE and 2-D PAGE 
patterns of the nuclear proteins was also carried out. The specific objectives 
are to:
1. Subclone the 882 bp DNA fragment of the upstream region of ME gene 
into pUC19 and restrict this insert into fragments of the appropriate 
sizes to be used in band shift assays.
2. Perform gel retardation assays using nuclear proteins from obese  and 
lean Zucker rat liver and different fragments from the upstream region of 
the ME gene to identify those regions of the upstream DNA that are 
involved in the regulation of the rate of transcription in the rat and, 
hence, are regulated differently in the lean and obese animals. This 
would enable us to identify the site-specific DNA binding proteins in 
nuclear extracts from lean and obese rats.
3. Carry out the sam e type of experiments using the identified DNA 
fragment(s) and nuclear extracts from lean and obese animals that have
36
been adrenalectomized. These binding studies were done in the 
presence and absence of glucocorticoid hormones, and the results were 
compared to those of the normal lean and obese animals. This will 
make it possible to identify the protein that is involved in the 
glucocorticoid control of ME gene.
4. Investigate the effect of dephosphorylation and phosphorylation on the 
formation of the DNA-protein complexes.
5. Analyze the nuclear proteins present in the specific DNA-proteins 
complexes.
6. Analyze the hepatic nuclear extracts using SDS PAGE and 2-D PAGE.
MATERIALS AND METHODS
Bacterial strains and plasmids
The bacteria strains and plasmid vectors used in this study are 
described in Table 3.
Media and growth conditions
All bacteria strains were routinely subcultured in LB medium (250) at 
37°C, Liquid cultures were aerated vigorously. 1.5% (w/v) agar w as added 
for solid media. Ampicillin when used w as added to media at 100 pg/ml. 
Chemicals and reagents
pUC19 DNA, 10 X ligation buffer, T4 DNA ligase, DNA polymerase I 
large (Klenow) fragment, VentR® (exo') DNA polymerase, and all restriction 
enzym es used in this study were purchased from New England Biolab; 
Ethylenediaminetetraacetate (EDTA), dithiothreitol (DTT), 
phenylmethylsulfonyl fluoride (PMSF), pepstatin A, leupeptin, ethidium 
bromide, nonidet P-40, 5-bromo-4-chloro-3-indolyl-p-D-galactoside (X-gal), 
isopropylthio-a-D-galactoside (IPTG), magnesium acetate, potasium chloride 
(KCI), triton X-100, calf intestine alkaline phosphatase (CIAP), protein kinase 
A (PKA), myosin, phosphorylase A, catalase, actin, carbonic anhydrase, 
lysozyme and ampicillin were purchased from Sigma Chemical Company; 
protein kinase C (PKC) was purchased from Boehringer Mannheim; 
AmpliTaq DNA Polymerase was purchased from Perkin Elmer Cetus; 
SeaKem GTG agarose w as purchased from FMC BioProducts; Tris-HCI, 
Glycine, Magnesium chloride (MgCI2), and 10 X TBE buffer were purchased
37
38
Table 3. Plasmids and host cells
Genotype Reference
Host Cells:
JM83 araA(lac-proAB) rpsl (strA) (<J> 
80/acZAM15)
251
INVaF F’ encfAl necA1 hsdR17 (rk",mk') 
supE44 thi-1 gyrA96 re/A1 $80lacZ 





pUC19 _ Apr 255
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from AMRESCO; Magic Miniprep Kit w as purchased from Promega; 10 X 
Polymerase Chain Reaction (PCR) buffer was purchased from Invitrogen; 
Ammonium acetate was purchased from Fisher Scientific; Sodium dodecyi 
sulfate (SDS) and glycerol were purchased from United S tates Biochemicals; 
2 ’-deoxyadenosine 5’-triphosphate (dATP), 2'-deoxycytidine 5-triphosphate 
(dCTP), 2’-deoxyguanosine 5’-triphosphate (dGTP), 2’-deoxythymidine 5'- 
triphosphate (dTTP), deoxyribonucleoside triphosphates (dNTPs), and 
poly(dl-dC)*poly(dl-dC) were purchased from Pharmacia; [<x-32P]dATP or [a- 
32P]dGTP was purchased from DuPont; Sucrose was purchased from 
GIBCO BRL; Anti-glucocorticoid monoclonal antibody (BuGR2) was 
purchased from Affinity BioReagent; Anti-HNF3a antiserum w as a gift from 
Dr. Jam es Darnell.
Subcloning of a 882-bp upstream region of ME gene
The plasmid pME882-CAT (Figure 2) which contains the ME 5' 
flanking region was provided by V. M. Nikodem (245). After digestion of 
pME882-CAT with restriction enzymes EcoRI and Pstl, the reaction mixture 
w as loaded onto a 0.7% agarose gel and the gel was run at 40 V overnight 
in 1 X TBE buffer (0.09 M Tris-borate, 0.002 M EDTA, pH 8.0). After the gel 
w as stained with ethidium bromide for 10 min and washed with water for 10 
min, a band of 942-bp was seen under UV light (Figure 3). This band, which 
contains the 882-bp upstream region of ME gene, w as excised from the gel, 
cut into small pieces (dimension approximately 2 mm x 2 mm x 5 mm), and 
packed into a  0.5 ml inner elution tube which had been filled with 1 X TBE 
buffer. The DNA fragment was eluted using a Hoefer Scientific Instruments 










Figure 2. The map of pME882-CAT. The CAT gene is indicated by a solid 
arrow. The 925 bp upstream region of ME gene carried by this piasmid is 
shown as a shaded bar. Restriction sites are indicated and numbered 
according to their distance to the EcoRI site.
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O  942 bp
Figure 3. Generation of the 942 bp DNA fragment. Digestion of pME882- 
CAT with EcoRI and Pstl gave rise to a 942 bp DNA fragment that contains 
the 925 bp upstream region of the ME gene. Lane 1 shows the 1 kb DNA 
ladder used a s  a DNA size marker. Lane 2 shows the digestion reaction 
resolved on a 0.7% agarose gel. The position of the 942 bp DNA fragment in 
lane 2 is indicated by an arrow on the right.
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centricon (Amicon) with a cut-off of 10,000 MW, centrifuged at 3500 rpm in 
an International Equipment Company HN-SH centrifuge at 4°C for 3 hours. 
100 ng of the 942-bp DNA and 100 ng of pUC19 DNA, which had been 
digested with EcoRI and Pstl, were added into a ligation reaction which 
contained 1 X ligation buffer and 400 units of T4 DNA ligase in a  total 
volume of 20 pi. The ligation reaction was carried out at 16°C overnight. The 
recombinant DNA was then transformed into competent JM83 cells following 
the procedures described by Maniatis et al. (256) The transfected cells which 
contained recombinant plasmid were identified as white colonies by plating 
dilutions of the transformation on L-agar, into which 10Opg/ml ampicillin had 
been added, in the presence of the chromogenic substrate X-gal and the 
gratuitous inducer of p-galactosidase IPTG. The recombinant plasmid was 
purified using Magic Miniprep Kit. After digestion of the plasmid with 
restriction enzym es Aflll-Notl and Notl-Pstl, the insert was confirmed by 
loading the restriction digestion mixture onto a 5% polyacrylamide gel 
electrophoresis (PAGE) and run at 25 V, overnight with 1 X TBE a s  running 
buffer (Figure 4). The recombinant plasmid was named pME925 (Figure 5).
Two other DNA fragments, representing -881 to -696 and -712 to -491 
of the ME gene, were generated by polymerase chain reaction (PCR) 
amplification using gel purified, EcoRI digested pME925 as template. The 
primers used in the PCR reactions were designed using a primer designer 
program, Primer 2 (Scientific & Educational Software) and were synthesized 
by the GeneLab at the School of Veterinary Medicine Louisiana State 
University. The nam es and sequences of the primers are shown in Table 4. 
The PCR reactions were performed in a Perkin Elmer Cetus DNA thermal
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Figure 4. Generation of the 134 bp and 385 bp DNA fragments. Digestions of 
the plasmid pME925 with Notl-BamHI and Aflll-Notl gave rise to a 134 bp 
and 385 bp DNA fragments, respectively. Lane 1 shows the 100 bp DNA 
ladder used as a DNA size marker. Lane 2 (Notl/BamHI) and 3 (Aflll/Notl) 
contain the digestion reactions resolved on a 5% PAGE. Positions of the 134 
bp and 385 bp DNA fragments are  indicated by the arrows on the right.
44





















1000 JP.BimHI.OIl U PKI.M2
7000 ISOO
Figure 5. Cloning of a 945 bp EcoRI-Pstl DNA fragment into pUC19 vector. 
The plasmid pME882-CAT was digested using EcoRI and Pstl and a 942 bp 
DNA fragment containing ME upstream region was isolated. The DNA 
fragment w as then ligated into EcoRI-Pstl digested pUC19 vector.









cycler. Each PCR reaction consisted of 90 ng of the template DNA, 1 X PCR 
buffer, 0.5 mM dATP, 0.5 mM dCTP, 0.5 mM dGTP, 0.5 mM dTTP, 1 pM of 
each of the two primers, and 1 unit of the thermostable Taq DNA polymerase 
in a  total volume of 50 pi. The primers MECLN1A and MECLN1B were used 
in the PCR reaction to generate the 186 bp DNA fragment and the primers 
MECLN2A and MECLN2B were used in the PCR reaction to generate the 
222 bp DNA fragment. Because the non-template dependent activity of the 
thermostable polymerase used in PCR adds single deoxyadenosines to the 
3’-end of all duplex molecules, the resulting 186 bp and 222 bp DNA 
fragments were ligated into the specifically designed plasmid vector 
Invitrogen pCR™ll, which provides single 3' T-overhangs at the insertion 
site. The thermocycles used are described in Table 5. The recombinant 
plasmid generated using primers MECLN1A and MECLN1B was designated 
pME186 and the one generated using primers MECLN2A and MECLN2B, 
pME222 (Figure 6).
End labeling target DNA
Labeled DNA fragments used in the band shift assays were prepared 
by digestion of the plasmids pME925, pME186 or pME222 with different 
restriction enzym es and filling in with either [a-32P]dATP or [a-32P]dGTP 
depending on the sequences of the 3-recessive ends of the fragments.
The plasmid pME925 was digested with the restriction enzym es Aflll- 
Notl or Notl-BamHi, the plasmid pME186 w as digested with EcoRI, and the 
plasmid pME222 w as digested with EcoRI and EcoRI-PflMI.
The labeling reactions were carried out with 1 pg digested plasmid 
DNA, 0.5 mM dNTPs as needed, 0.825 pM (50 pCi) [a-32P]dATP or
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Table 5. Thermocycles used for PCR
Names of Primers 
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Figure 6. Construction of the plasmids pME186 and pME222. A 186 bp and 
a  222 bp DNA fragments were obtained using PCR. The 942 bp DNA 
fragment w as used a s  the template. The DNA fragments were then ligated 
into the pCRII vector which provides single 3’ T-overhangs at the insertion 
site. The solid bar represents the 925 bp upstream region of the ME gene. 
The restriction sites were indicated above the solid bar. The positions of the 
two DNA fragments relative to the 925 bp upstream region of ME gene are 
shown with the hatched bars below the solid bar.
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[a-32P]dGTP and 5 units Klenow fragment in a total volume of 20 pi. After 
incubation at 37°C for 15 min, the labeling mixtures were loaded onto a 5% 
polyacrylamide gel and electrophoresed at 200V, room tem perature for 40 to 
60 min. And the bands were visualized by staining with ethidium bromide a s  
described above. The bands were then cut out of the gel with a  lancet and 
transfered into a  microcentrifuge tube containing 200 pi elution buffer which 
is com posed of 0.5 M ammonium acetate, 1 mM EDTA, 10 mM magnesium 
acetate, and 0.1% SDS, and shaken at 225 rpm in a  37°C incubator 
overnight. The elution buffer containing the DNA fragments w as then 
transfered to another microcentrifuge tube and the gel slices were eluted 
with a second 100pl elution buffer and the eluate combined. After adding 30 
pi sodium acetate (pH 5.4), 750 pi of ethanol was added and the mixture 
cooled to -75°C for 15 min. The tube was then centrifuged at 14,000 rpm, 4° 
C for 10 min in an eppendorf 5402 centrifuge. The pellet was then washed 
with 70% ethanol. After vortexing briefly, the tube was centrifuged at 14000 
rpm, 4°C for 10 min. The pellet was then dried in a vacuum cham ber for 15 
min, desolved in 100 pi deionized and distilled water and stored at 4°C. The 
specific activity of the labeled probes were m easured using a Beckman 
LS6000TA liquid scintillation system and were between 12,000 to 15,000 
cpm/pl.
PCR amplification and labeling of the 49-bp probe
A 49 bp DNA fragment containing a GRE site w as generated and 
labeled with [a-32P]dATP using PCR. The primers designed for the PCR 
reaction were synthesized by the GeneLab at the School of Veterinary 
Medicine Louisiana State University and are shown in Table 4. The PCR
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reaction w as carried out in a  50 pi solution containing 90 ng of EcoRI 
digested pME925 DNA as template, 1 X PCR buffer, 0.5 mM dTTP, 0.5 mM 
dGTP, 0.5 mM dCTP, 1.65 pM (100 pCi) [a-32P]dATP, 1 pM of each of the 
primers (ME49A and ME49B), and 1 unit VentR® (exo') DNA polymerase 
which does not degrade the PCR product when there are unequal dNTP 
concentrations and has a  fidelity level twice that of Taq DNA polymerase. 
The thermocycles are  described in Table 5. The PCR reaction w as then 
loaded onto a 5% non-denaturing polyacrylamide gel and purified a s  
described above.
Animals
Zucker lean and obese  rats from two sources have been used in the 
described experiments. In the gel retardation experiments obese (fa/fa) and 
lean (Fa/fa or Fa/Fa) rats were bred from heterozygote parents. For SDS 
PAGE and 2-D PAGE analysis, we used rats from a  Zucker X Brown Norway 
cross colony to identify known homozygous lean (Fa/Fa) and obese (fa/fa) 
rats. This cross provides a restriction fragment length polymorphism close to 
the fa gene that allows determination of the number of fa genes carried with 
an error of less than 1% (257).
All rats were bred in the AALAC-accredited animal facility of the 
Pennington Biomedical Research Center. They were housed singly, after 
weaning at 21 days, in hanging wire cages with an automated water system  
in rooms maintained at 22-240C with a 12 hour (08.00 to 20.00 hour) light- 
dark cycle. Food (laboratory rodent #5001, PMI Feeds Inc.) w as available ad 
libitum.
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Bilateral adrenalectomies or sham -operations were performed under 
metofane anesthesia as described previously (116). During the immediate 
24-hour postoperative period all rats were maintained at 24-26°C, before 
being returned to normal housing temperature. Adrenalectomized rats were 
maintained on a 0.9% (w/v) saline drinking solution. Som e adrenalectomized 
rats were treated with dexam ethasone (0.5 mg/kg body weight, daily) for two 
days before sacrifice, which was seven days after the operation. The 
dexam ethasone was injected intraperitoneally in an Tween-20/ethanol/0.9% 
(w/v) NaCI (1:25:975, by volume) vehicle. All control animals received a 
similar volume of vehicle. Immediately after decapitation of the rats, trunk 
blood w as collected for the preparation of serum. The success of the 
adrenalectomy procedure was confirmed by demonstration of undetectable 
serum corticosterone levels in a radioimmunoassay procedure as previously 
described (116).
Preparation of hepatic nuclear extracts
Nuclear proteins were prepared from extracts of purified nuclei of lean 
and obese Zucker rats by the method of Bernal e t al. (258). All manipulations 
were performed in the cold, and all solutions, tubes, and centrifuges were 
chilled to 0°C. When included, DTT, PMSF, Pepstatin A, and Leupeptin were 
added to the buffers just prior to use. Rats were decapitated at the age of 4- 
6 weeks. 7.5 g liver was minced and homogenized in SMDP solution 
containing 0.32 M sucrose, 1 mM MgCI2l 1 mM DTT, 1 mM PMSF, 1 pM 
pepstatin A, and 1 pM leupeptin, and centrifuged at 1090 x g in a Beckman 
J2-21M centrifuge for 10 min. The pellet was washed with SMDP solution, 
resedimented and resuspended in 2.4 M sucrose containing 1 mM PMSF
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and 1 mM DTT. It was centrifuged in a Beckman fixed angle Ti 50.2 rotor at
130,000 xg for 45 min. The pellet was resuspended in 9 ml of SMTDP 
solution (0.32 M sucrose, 1 mM MgCI2l 1 mM DTT, 1 mM PMSF) to which 
250 pi of 10% triton X-100 was added. After incubation at 4°C for 5 min, the 
pellet was sedimented at 1090 xg in a Beckman J2-21M centrifuge for 10 
min and washed with 10 ml of SMTDP solution. The pellet w as used as 
purified nuclear fraction. The purified nuclei were lysed in 10 mM Tris-HCI 
buffer pH 8.0 containing 0.4 M KCI, 1 mM MgCI2, 1 mM DTT, 1 mM PMSF, 
incubated for 1 hour with occasional mixing, centrifuged in Beckman Ti 50.2 
rotor at 150,000 x g for 1 hour. The supernatant was frozen with liquid 
nitrogen in small aliquots and was stored at -80°C. It was used a s  nuclear 
protein extract in the gel retardation studies, SDS PAGE, and 2-D PAGE. 
Protein content was assayed using the Bio-Rad dye binding method of 
Bradford (259). Once thawed, the extracts were not refrozen.
Gel retardation studies
Binding reactions were carried out basically a s  described by Petty et 
al. (248). 1 or 2 pg of Zucker rat liver nuclear extract was added to 20 pi of 
binding buffer containing 125 mM Tris-HCI (pH 8.0), 25 mM MgCI2 (to adjust 
ionic strength), 2.5 mM EDTA (as a chelation agent), 50% glycerol (to 
stabilize the binding), 0.1% Nonidet P-40 (to minimize aggregation), 2.5 mM 
dithiothreitol (as a  reducing agent), 250 mM NaCI (to adjust ionic strength), 
and 0.5 mg/ml poly(dl-dC)*poly(dl-dC) (as a  nonspecific competitor DNA). 2 
pi of labeled probe w as then added and incubation w as continued for 20 min 
at room temperature. After addition of 2 pi of 10X loading buffer (0.1% 
bromphenol blue and 50% glycerol) reaction mixtures were loaded onto a
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1.5 mm x 14 cm x 16 cm polyacrylamide gel (4 or 5%, 
acrylamide:bisacrylamide, 37.5:1) that had been pre-electrophoresed at 100 
V for a t least 30 minutes in a  buffer of 50 mM Tris, 0.38 M glycine, 2 mM 
EDTA, pH 8.3. Electrophoresis was carried out at 200 V, 4°C until the 
bromphenol blue dye front reached the bottom of the gel. Gels were dried 
and exposed to a Molecular Dynamics Phosphoimager screen or an X-ray 
film.
Gel shift interference experiments were carried out under the sam e 
conditions a s  described above for the gel retardation assay  except that after 
adding nuclear extract in the binding buffer, the incubations were carried out 
in the presence of specified amount of phosphatase, protein kinases, or 
antibodies. CIAP, PKA, or PKC w as incubated with the nuclear proteins at 
30°C for 30 min. BuGR2 or HNF3a antiserum was incubated with the 
nuclear proteins at room tem perature for 20 min.
SDS PAGE of proteins in DNA-protein complexes from band shift 
assays
In order to analyze the proteins present in the bands of interest in the 
band shift assays, 15 fold scale-up band shift assays were performed with 
the 222 bp DNA fragment a s  labeled probe. Band shift assays were carried 
out a s  described above except that two control reactions were run without 
any target DNA added. After exposure to the X-ray films, the original gels 
were aligned with the X-ray films and the bands of interest were excised from 
the gel. The gels in which control reactions were loaded were also aligned 
with the X-ray films obtained from band shift assays performed with labeled 
probes and the gel slices at the sam e position were excised. The excised gel 
slices were chopped into small pieces and the proteins in the gels were
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eluted using a Hoefer GE 200 Eluter a t 4°C, 200 V for 3 hours. The eluted 
proteins were then concentrated using an Amicon centricon (10,000 M.W. 
cut-off) a s  described above. After denaturation at 95°C for 5 min in the 
SDS/sample buffer (5% SDS, 5% beta-mercaptoethanot, 10% glycerol and 
60 mM Tris, pH 6.8), the concentrated proteins were loaded onto a  Millipore 
pre-cast 4-20% SDS polyacrylamide gel (8 cm x 7 cm x 1 mm) and run at 
200 V for 1 hour in a Hoefer SE 250 Mighty Small II Vertical Slab Unit. 
BioRad SDS-PAGE Molecular Weight Standards was also loaded on the gel 
to show the sizes of the proteins. The gel was then stained with the BioRad 
silver stain kit following the instruction provided by the manufacturer. Black 
and white pictures of the stained gel were then taken using a  Nikon 700 
camera.
Analysis of the hepatic nuclear proteins using polyacrylamide gel 
electrophoresis
SPS PAGE
Hepatic nuclear proteins from obese and lean Zucker rats were 
subjected to SDS PAGE. 5 pg of each of the nuclear extracts was heated at 
95°C for 5 min in 50 pi of SDS/sample buffer and loaded onto an 8% SDS 
PAGE (1.5 mm x 16 cm x 12 c m ). The gel was run at 10 mA until the 
bromphenol blue dye front reached the bottom of the gel. The gel was then 
silver stained and its pictures taken as described above.
2-D PAGE
Two-dimensional electrophoresis was performed according to the 
method of O'Farrell (260) by Kendrick Labs, Inc. (Madison, Wl) as follows:
Isoelectric focusing w as carried out in glass tubes of inner diameter
2.0 mm, using 2.0 Resolytes pH 4-8 ampholines (BDH from Hoefer Scientific
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Instruments) for 9600 volt-hours. One pg of an IEF internal standard, 
tropomyosin protein, with lower spot of M.W. 33,000 and pi 5.2 was added to 
the sam ples. This standard is indicated by an arrow on the stained 2-D gel.
After equilibration for 10 min in a buffer containing 10% glycerol, 50 
mM dithiothreitol, 2.3% SDS and 0.0625 M Tris, pH 6.8, the tube gels were 
sealed to the top of stacking gels which are on top of 10% acrylamide slab 
gels (0.75 mm thick) and SDS slab gel electrophoresis carried out for about 
4 hours at 12.5 mA/gel. The following proteins were added a s  M.W. 
standards to the agarose which sealed the tube gel to the slab gel: myosin 
(220,000), phosphorylase A (94,000), catalase (60,000), actin (43,000), 
carbonic anhydrase (29,000) and lysozyme (14,000). These standards 
appear as horizontal lines on the Coom assie Brilliant Blue R-250 stained 
10% acrylamide slab gels. The Coom assie blue stained gels were dried 
between sheets of cellophane with the acid edge to the left.
For protein purification, the slab gels were transferred to transfer 
buffer (12.5 mM Tris, pH 8.8, 86 mM glycine, 10% methanol) transblotted 
onto PVDF paper overnight at 4°C, 200 mA and approximately 100 V/2 gels. 
The m em branes were stained in 50% methanol and 0.1% Coomassie 
Brilliant Blue for 5 min, destained in 50% methanol for 2 min and rinsed 10 
minutes six times in ultrapure water. The m em branes were then dried 
between sheets of filter paper. The protein spots of interest were cut out of 
the PVDF paper with a razor blade and sent to Baylor College of Medicine 
for gas phase sequencing analysis.
RESULTS
Subcloning of ME 5' flanking region
The 942 bp EcoRI-Pstl fragment containing the 5’ flanking region was 
subcloned from pME882-CAT into pUC19 (Figure 5). The entire sequence of 
the recombinant plasmid was determined using the Wisconsin Sequence 
Analysis Package™  (Genetics Computer Group, Inc.). The insert was 
confirmed by restriction analysis (Figure 3). The sequences of the PCR 
subcloned inserts in the recombinant plasmids pME222 and pME186 were 
also determined. The digestion of pME925 with different restriction enzym es 
gave rise to a 385 bp fragment (Aflll-Notl) and a  134 bp fragment (Notl- 
BamHI) (Figure 4). The digestion of pME222 with EcoRI yielded a 222 bp 
fragment (Figure 7), while a  double digestion of the sam e plasmid with EcoRI 
and PfIMI generated two other fragments with the length of 70 bp and 152 bp 
respectively (Figure 8). The 186 bp fragment was obtained by cutting the 
pME186 with EcoRI (Figure 7).
The TRE, IRE-II, and AP-1 sites fall into the 385 bp fragment. The 
GRE, IRE-I, and HNF3 sites fall into the 222 bp fragment, with the GRE in 
the 152 bp fragment, while the IRE-I and HNF3 sites are contained in the 70 
bp fragment (Figure 1, Table 2).
Binding of the nuclear extracts to the DNA fragments
The first goal of this study was to verify the hypothesis that the higher 
hepatic ME mRNA level in obese Zucker rats is caused by enhanced 
transcription activation of the ME gene. As would be described below, this 
hypothesis w as proven true. The next step was to identify the location of the
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Figure 7. Generation of the 222 bp and 186 bp DNA fragments to be used in 
the band shift assays. Digestions of the plasmids pME222 and pME186 with 
EcoRI gave rise to a 222 bp and 186 bp DNA fragments, respectively. Lane 
1 shows the 100 bp DNA ladder used as a DNA size marker. Lane 2 
(pME186) and 3 (pME222) contain the digestion reactions resolved on a  5% 
PAGE. Positions of the 222 bp and 186 bp DNA fragments are  indicated by 
the arrows on the right.
Figure 8. Generation of the 152 bp and 70 bp DNA fragments to be used in 
the band shift assays. Digestions of the plasmids pME222 with EcoRI-PflMI 
gave rise to a 152 bp and 70 bp DNA fragments, respectively. Lane 1 shows 
the 100 bp DNA ladder used as a DNA size marker. Lane 2 contains the 
digestion reaction resolved on a 5% PAGE. Positions of the 152 bp and 70 
bp DNA fragments are indicated by the arrows on the right.
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DNA sequences that are bound differentially by the nuclear extracts from 
obese and lean Zucker rats. Thus the band shift experiments were initially 
performed with five DNA fragments, which together cover the entire 882 bp 
upstream  region of the ME gene. The images obtained by scanning the 
phosphoimager screen are shown in Figures 9-10,12-14.
Band shift assay with the 134 bp DNA
The 134 bp DNA fragment used in the band shift assay  shown in 
Figure 9 was generated by digestion of the plasmid pME925 with Notl and 
BamHI and is located at -102 to + 33 of the ME gene (Figure 1). Up to seven 
bands were seen  when this 134 bp DNA fragment, which was labeled with 
[a-32P]dATP, was incubated with hepatic nuclear extract from lean and 
obese rats (Lanes 2 and 3 of Figure 9). The single band in lane 1 showed 
the position of the free labeled 134 bp DNA.
The specificity of the binding was demonstrated by competition 
experiments, in which the binding reaction was performed in the presence of 
excess unlabeled competitor. In lanes 4 and 5, 30-fold of unlabeled target 
DNA (the 134 bp fragment) was included in the binding reaction a s  a 
competitor. As can be seen, the bands that represent the formation of the 
DNA-protein complexes disappeared with the addition of the unlabeled 
competitor. Thirty fold of sonicated E. coli DNA was included in the binding 
reactions shown in lanes 6 and 7, and the formation of the DNA-protein 
complexes were not competed by this unrelated DNA.
There was no significant difference between the levels at which this 
134 bp DNA fragment w as bound by the hepatic nuclear proteins from obese 
and lean rats (Appendix A). The overall patterns by which the nuclear
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1 2 3 4 5 6 7
Labeled DNA + + + + + + +
Nuclear Extract - 0 L O L O L
Cold Target DNA - - - + + - -
Unrelated DNA + +
[C3 Complex 5
KJ3 Complex 6
Figure 9. Band shift assay  with the 134 bp fragment. Hepatic nuclear 
extracts prepared from obese and lean Zucker rats were incubated with 32P- 
labeled DNA fragments containing the -102 bp to +33 bp region of ME gene, 
together with or without unlabeled target DNA or E. coli DNA. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrows on the right indicate the 
positions of the shifted complexes. +: present, -: absent, O: obese, L: lean.
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proteins bind to the 134 bp DNA fragment were sam e in obese and lean 
animals.
Baitd_shift_assay with the 385 bp DNA
The 385 bp DNA fragment located between -488 and -103, the region 
which contains a  TRE, Sp1, AP-1 and the IRE-il. It was prepared by 
digestion of pME925 with Not) and Aflll (Figure 4) and labeled with [a- 
32P]dGTP using Klenow fragment. The binding of the nuclear proteins from 
obese and lean Zucker rat liver to the labeled 385 bp DNA fragment resulted 
in four major bands in the band shift assay  shown in Lanes 2 (lean nuclear 
proteins) and 3 (obese nuclear proteins) in Figure 10. The position of the 
unbound labeled target DNA was shown in lane 1 which serves as a  control.
It w as obvious in all the four bands shown in lanes 2-3 that more 
hepatic nuclear proteins from obese Zucker rats bound to the 385 bp DNA 
when compared to lean Zucker rats (Appendix B). The formation of all the 
four DNA-protein complexes are  specific because the addition of 30-fold 
excess unlabeled target DNA competed with and replaced the labeled DNA 
(lanes 4-5) in the bands that were shown in lanes 2-3 and the inclusion of 
unrelated DNA did not change the formation of any of the bands (lanes 6-7).
The difference between the binding of nuclear proteins from obese 
Zucker rats and that from lean Zucker rats was in the amount of the DNA 
that was bound.
Band shift assay with the 222 bp DNA
The region from -712 to -491 of ME gene is covered by a 222 bp DNA 
fragment which contains an HNF3 binding site, an IRE-I, a TATA box, and a
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1 2 3 4 5 6 7
Labeled DNA 
Nuclear Extract 
Cold Target DNA 
Unrelated DNA
O  Complex 1 
C3 Complex 2
O  Complex 3 
<£* Complex 4
Figure 10. Band shift assay  with the 385 bp fragment. Hepatic nuclear 
extracts prepared from obese and lean Zucker rats were incubated with 32P- 
labeled DNA fragments containing the -488 bp to -103 bp region of ME gene, 
together with or without unlabeled target DNA or E. coli DNA. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrows on the right indicate the 
positions of the shifted complexes. +: present, -: absent, O: obese, L: lean.
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potential GRE site (Figure 1). It was obtained by digestion of pME222 with 
EcoRI and radioisotope-labeled using Klenow fragment.
At least four bands were seen  when this fragment, labeled with [a- 
32P]dATP, was incubated with the nuclear proteins from both obese and lean 
Zucker rat liver (lanes 2-3 in Figure 11). Lane 1 in Figure 11 has only the 
labeled 222 bp fragment and was used as a control reaction. Band shift 
assays performed in the presence of 30-fold of unlabeled 222 bp fragment 
DNA (lane 4) showed a disruption of the binding by the nuclear proteins to 
the labeled target DNA. Addition of 30-fold of sonicated E. coli DNA to the 
band shift assay  failed to affect the binding of the nuclear proteins to the 
labeled target DNA.
Interestingly, the pattern of binding of hepatic nuclear proteins to this 
222 bp DNA fragments were clearly different between obese and lean rats 
(lanes 2-3 in Figure 11). There was more Complex 1 formed by obese 
nuclear extract than by lean nuclear extract. On the other hand, there was 
more of complex 2, 3, and 4 formed by lean nuclear extract than by obese 
nuclear extract (Appendix C). Therefore, this region was selected for more 
thorough examination a s  will be described below.
Band shift assay with the 186 bp DNA
The 186 bp DNA fragment from -881 to -696 of ME gene was 
obtained by digestion of pME186 with EcoRI and labeled with [a-32P]dATP 
using Klenow fragment. It does not contain any known protein binding site. 
However, there were still two DNA-protein complexes formed when this 186 
bp fragment was used in band shift assay  (Figure 12). The formation of 
these  DNA-protein complexes was specific because the addition of 30-fold
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1 2 3 4 5 6 7
Labeled DNA 
Nuclear Extract 
Cold Target DNA 
Unrelated DNA
O  Complex 1
C 1 Complex 2 
C 1 Complex 3
C3 Complex 4
Figure 11. Band shift a ssay  with the 222 bp fragment. Hepatic nuclear 
extracts prepared from obese and lean Zucker rats were incubated with 32P- 
labeled DNA fragments containing the -712 bp to -491 bp region of ME gene, 
together with or without unlabeled target DNA or E. coli DNA. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrows on the right indicate the 
positions of the shifted complexes. +: present, absent, O: obese, L: lean.
+ + + + + + +
- 0 L O L 0 L
- - - + + - -
+ +
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1 2 3 4 5 6 7
Labeled DNA + + + + + + +
Nuclear Extract - 0 L 0 L 0 L
Cold Target DNA - - - + + - -
Unrelated DNA + +
Complex 1
KJ3 Complex 2
Figure 12. Band shift a ssay  with the 186 bp fragment. Hepatic nuclear 
extracts prepared from obese and lean Zucker rats were incubated with 32P- 
labeled DNA fragments containing the -881 bp to -696 bp region of ME gene, 
together with or without unlabeled target DNA or E. coli DNA. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrows on the right indicate the 
positions of the shifted complexes. +: present, absent, O: obese, L: lean.
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excess of unlabeled 186 bp target DNA negated the formation of the 
complexes by the nuclear proteins from obese and lean Zucker rat liver, and 
labeled target DNA and the inclusion of 30-fold excess of unrelated DNA did 
not affect the formation of these DNA-protein complexes.
There was a difference between the levels at which this 186 bp DNA 
fragment was bound by the hepatic nuclear proteins from obese and lean 
rats. It w as bound at a much higher level by nuclear proteins from obese rat 
liver than by the ones from lean rat (Appendix D). However the pattern of 
binding of hepatic nuclear proteins was similar in extracts from obese and 
lean rats.
Band shift assay with the 49 bp DNA
To investigate the binding of the nuclear proteins from obese and lean 
Zucker rat liver to the GRE site, a 49 bp DNA fragment was generated and 
labeled with [a-32P]dATP using PCR (Figure 13) a s  described in Materials 
and Methods. It covers the region -511 to -463 of the ME gene and contains 
only a GRE site (Figure 1, Table 4).
A single DNA-protein complex was seen  when this 49 bp DNA 
fragment was used a s  labeled probe in the band shift assay  with nuclear 
proteins from obese and lean Zucker rat liver (lanes 2 and 5 in Figure 14). 
There was a  higher concentration of proteins that bind to this 49 bp DNA 
fragment in obese Zucker rats when compared to lean (Appendix E). The 
formation of these  DNA-protein complexes w as specific because the addition 
of 30-fold excess unlabeled target DNA competed with and replaced the 
labeled DNA (lanes 3 and 6) in the bands that were shown in lanes 2 and 5
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Figure 13. Generation of the 49 bp DNA fragment to be used in the band 
shift assays. PCR amplication using the 925 bp DNA fragment a s  template 
and the oligonucleotides ME49A and ME49B as primers gave gave rise to a 
49 bp and 70 bp DNA fragments, respectively. Lane 1 shows the 100 bp 
DNA ladder used a s  a  DNA size marker. Lane 2 contains the digestion 
reactions resolved on a 5% PAGE. Positions of the 49 bp DNA fragments 
are indicated by the arrow on the right.
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1 2 3 4 5 6 7
Labeled DNA + + + + + + +
Nuclear Extract - O 0 0 L L L
Cold Target DNA - - + - - + -
Unrelated DNA - - - + - - +
i M i » « * *
Figure 14. Band shift assay  with the 49 bp fragment. Hepatic nuclear 
extracts prepared from obese and lean Zucker rats were incubated with 32P- 
labeled DNA fragments containing the -511 bp to -463 bp region of ME gene, 
together with or without unlabeled target DNA or E. coli DNA. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrow indicates the position of the 
shifted complexe. +: present, absent, O: obese, L: lean
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and the inclusion of unrelated DNA did not change the formation of any of 
the bands (lanes 4  and 7).
Adrenalectomy abolishes the binding of nuclear extract to ME222
Because adrenalectomy has been reported to be able to prevent or 
suppress the development of almost all the experimental obesity models, 
including Zucker rats (46), and the mRNA level of hepatic ME in obese 
Zucker rats has also been shown to be reduced to the level of that in lean 
Zucker rats (130), it was of interest for us to investigate the effect of 
adrenalectomy on band shift patterns with the upstream region of the ME 
gene. Since the pattern of binding of the hepatic nuclear proteins from obese 
and lean Zucker rats to the 222 bp DNA fragment, which contains a GRE 
site, an IRE-I site, and an HNF3 binding site, was shown to be different. We 
chose this 222 bp DNA fragment to further study the effect of the status of 
adrenal glucocorticoids on the binding of the hepatic nuclear proteins.
When nuciear extracts from sham  animals were used in the band shift 
assay , there was more Complex 1 formed by hepatic nuclear proteins from 
obese  animals than by that from lean animals (lanes 2-3 in Figure 15, 
Appendix F), and there were slightly less Complexes 2-4 formed by hepatic 
nuclear proteins from obese Zucker rats than by those from lean Zucker rats. 
This was consistent with the results obtained from the band shift assays 
performed with nuclear extracts from obese and lean Zucker rats that did not 
receive any surgery. This indicated that the sham  operation did not affect the 
binding of the nuclear proteins to the 222 bp fragment. The single band in 
lane 1 in Figure 15 indicated the position of the labeled 222 bp target DNA 
when it w as not bound by any proteins.
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C 1 Complex 1
O  Complex 2 
G3 Complex 3
G3 Complex 4
Figure 15. The effect of adrenalectomy on band shift pattern with the 222 bp 
fragment. Hepatic nuclear extracts prepared from obese and lean Zucker 
rats that had been adrenalectomized, adrenalectomized and dexam ethasone 
treated, or sham  operated, were incubated with 32P-labeled DNA fragments 
containing the -712 bp to -491 bp region of ME gene. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrows on the right indicate the 
positions of the shifted complexes. +: present, absent, O: obese, L: lean,
S: sham , A: adrenalectomy, D: dexam ethasone.
71
The formation of Complex 1 by adrenalectomized obese rat nuclear 
extracts w as reduced to approximately the level lower than that of sham  lean 
rat nuclear extracts (lane 4) and the Complex 1 formed by adrenalectomized 
lean nuclear extracts was reduced even further (lane 5). After 
dexam ethasone treatment, the obese adrenalectomized rat nuclear extracts 
evidenced a larger amount of proteins that bind to the 222 bp DNA fragment 
than sham  obese rat nuclear extracts (lane 6 in Figure 15, Appendix F) and 
the lean adrenalectomized rat nuclear extracts bound in a higher level to the 
222 bp DNA fragment than sham lean rat nuclear extracts although still 
slightly lower than sham  obese nuclear extracts.
The levels of complexes 2-4 formed by the hepatic nuclear proteins 
from adrenalectomized and dexam ethasone replaced obese  and lean 
Zucker rats were affected by the glucocorticoid status manipulation in an 
opposite way to the levels of Complex 1.
Dephosphorylation of nuclear proteins abolished the binding
Protein phosphorylation is one of the most frequent forms of 
posttranslational modification in eukaryotic cells and is linked to the control of 
a  variety of cellular functions (158, 222). Glucocorticoid receptor, a  steroid 
hormone receptor, is a  phosphoprotein and undergoes hyperphosphorylation 
after hormone-induced activation (177). Insulin receptor, a  representative of 
peptide hormone receptors, is not only a phosphoprotein, but also one of the 
receptor tyrosine kinases (184-189). Based on our above observation that 
there were differences between the patterns with which the hepatic nuclear 
proteins from obese and lean Zucker rats bind to the 222 bp DNA fragment, 
which contains both an IRE-I and a GRE, it was rational to further investigate
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the influence of the phosphorylation status of the hepatic nuclear proteins on 
their binding to the 222 bp DNA fragment.
First, we used CIAP to dephosphorylate the hepatic nuclear proteins 
from obese and lean Zucker rats. 0.2-4 units of CIAP was incubated with the 
nuclear proteins in the band shift reactions for 30 min before labeled probe 
w as added. As the amount of the CIAP increased, the formation of the 
specific DNA-protein Complexes 1-3 decreased, regardless of whether the 
hepatic nuclear proteins used in the band shift assays were from obese 
Zucker rats (lanes 4, 6, 8 ,10 ,12  in Figure 16) or lean Zucker rats (lanes 5, 7, 
9, 11, 13 in Figure 16, Appendix G). This suggested that one or more of the 
proteins that formed Complexes 1-3 need to be phosphorylated in order to 
bind to the DNA or interact with each other.
In contrast, the intensity of Complex 4 was increased when the 
amount of the CIAP increased, this w as the case  with complexes formed by 
both obese  and lean Zucker rats.
Phosphorylation of nuclear proteins did not increase the binding
Ideally, phosphorylation of the hepatic nuclear proteins from lean and 
obese Zucker rats should reverse the effects of dephosphorylation on the 
formation of the specific DNA-protein complexes. Specifically, it should 
increase the formation of Complexes 1-3 and decrease  the formation of 
Complex 4. In order to verify if this was the case, PKA, a cAMP-dependent 
protein Serine/Threonine kinase, was used to phosphorylate the hepatic 
nuclear proteins from obese and lean Zucker rats. It w as added into the 
binding reactions and incubated for 30 min just before the addition of labeled 
222 bp DNA fragment to initiate the binding. But, a s  indicated in Figure 17,
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1 2 3 4 5 6 7 8 9 10 11 12 13
Labeled DNA + + + + + + + + + + + + +
Nuclear Extract - O L O L O L O L O L O L
CIAP (U) - - - .2 .2 .4 ,4 .8 .8 2 2 4 4
$  c <P Complex 1
<P Complex 2 
<P Complex 3
<P Complex 4
Figure 16. Effect of dephosphorylation on band shift pattern with the 222 bp 
fragment. Hepatic nuclear extracts prepared from obese and lean Zucker 
rats that had been treated with specified amount of CIAP were incubated 
with 32P-labeled DNA fragments containing the -712 bp to -491 bp region of 
ME gene. DNA-protein complexes were size fractionated in nondenaturing 
polyacrylamide gels and were detected by autoradiography. The arrows on 
the right indicate the positions of the shifted complexes. +: present, -: absent, 
O: obese, L: lean.
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O  Complex 1
C3 Complex 2 
C3 Complex 3
C3 Complex 4
Figure 17. Effect of PKA treatm ent on band shift pattern with the 222 bp 
fragment. Hepatic nuclear extracts prepared from obese and lean Zucker 
rats that had been treated with specified amount of PKA were incubated with 
32P-labeled DNA fragments containing the -712 bp to -491 bp region of ME 
gene. DNA-protein complexes were size fractionated in nondenaturing 
polyacrylamide gels and were detected by autoradiography. The arrows 
indicate the positions of the shifted complexes. +: present, -: absent, O: 
obese, L: lean.
+ + + + + + + + + + + + + +
- 0 L O L O L O L O L - - - -
- - - .02 .02 .04 .04 .2 .2 2 2 .02 .04 .2 2
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phosphorylation of the hepatic nuclear proteins with PKA did not change 
their binding to the 222 bp DNA fragment (lanes 4-11), a s  compared to the 
control reactions in which no PKA w as used (lanes 2-3). Lanes 12-15 had no 
nuclear proteins and contained different amount of PKA. No extra bands 
other than the free probe was detected in lanes 12-15, indicating that PKA, 
although a protein itself, did not specifically bind to the 222 bp DNA 
fragment.
Suspecting that PKA was not the appropriate protein kinase to 
phosphorylate the nuclear proteins involved in the formation of the specific 
DNA-protein complexes in vivo, we explored the effect of phosphorylation of 
the hepatic nuclear proteins using PKC, another protein Serine/Threonine 
kinase which is activated by phosphatidylserine, diacylglycerol, and Ca++. 
With the addition of PKC in the binding reactions, phosphatidylserine and 
diacylglycerol, which were incubated with PKC for activation, were also 
present in the binding reactions. One DNA-protein complex w as seen  when 
the PKC treated hepatic nuclear proteins from obese and lean Zucker rats 
were incubated with the labeled 222 bp DNA fragment. The intensity of the 
complex was higher when the nuclear proteins from obese animals were 
used than when those from lean animals were used, which w as consistent 
with the result displayed in complex 1 when no diacylglycerol were included 
in the binding reaction (Figure 11). However, when PKC was included in the 
binding reactions, the DNA-protein complexes formed by the binding to the 
222 bp DNA fragment by the hepatic nuclear proteins from both obese and 
lean Zucker rats were dramatically reduced (lanes 4-5 in Figure 18). PKC
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1 2 3 4 5 6
Labeled DNA + + + + + +
Nuclear Extract - O L O L -
PKC (mU) - - - .3 .3 .3
Figure 18. Effect of PKC treatment on band shift assay  with the 222 bp 
fragment. Hepatic nuclear extracts prepared from obese and lean Zucker 
rats that had been treated with specified amount of PKC were incubated with 
32P-labeled DNA fragments containing the -712 bp to -491 bp region of ME 
gene. DNA-protein complexes were size fractionated in nondenaturing 
polyacrylamide gels and were detected by autoradiography. The arrow on 
the right indicates the position of the shifted complex. +: present, absent, 
O: obese, L: lean.
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itself w as shown not to bind to the labeled target DNA in lane 6, in which on 
nuclear proteins were added.
Binding of nuclear proteins to different regions of the 222 bp fragment
In order to further investigate the roles the different regions of the 222 
bp DNA fragment played in the formation of the DNA-protein complexes, we 
obtained two smaller DNA fragments, which together constitute the whole 
222 bp upstream region of ME gene (Figure 1), by digesting pME222 with 
the restriction enzym es EcoRI and PfIMI. The resulting 70 bp (containing the 
HNF3 binding site and the IRE-I site) and 152 bp (containing the GRE site 
and TATA box) DNA fragments were end labeled with [a-32P]dATP using 
Klenow fragment.
The binding of the hepatic nuclear proteins from both obese and lean 
Zucker rats to the 70 bp DNA fragment (-712 to -643) resulted in up to six 
DNA-protein complexes (Figure 19). The formation of the Complexes 1-2 
w ere so  weak that they appeared a s  two sm ears rather than two bands 
(lanes 1-2 in Figure 19). In spite of the weak binding, dephosphorylation of 
the nuclear proteins with CIAP completely abolished the already weak 
formation of the DNA-protein complex (lanes 4-9, Figure 19). The formation 
of Complex 3 w as also reduced by the dephosphorylation of the nuclear 
proteins from both obese and lean rats. In contrast, Complexes 5-7 were 
found increased by the sam e treatment. Interestingly, another band, named 
Complex 4, appeared with the dephosphorylation of the nuclear proteins and 
its intensity increased as the amount of CIAP was used. In all cases, the 
formation of Complexes 1-3 were stronger in obese animals than in lean 
animals when sam e amount of CIAP were used.
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Figure 19. Effect of dephosphorylation and adrenalectomy on band shift 
pattern with the 70 bp fragment. Hepatic nuclear extracts prepared from 
obese and lean Zucker rats that had been treated with specified amount of 
CIAP (lanes 2-9) or those from obese and lean Zucker rats that had been 
adrenalectomized, adrenalectomized and dexam ethasone treated, or sham  
operated (lanes 10-15) were incubated with 32P-labeled DNA fragments 
containing the -712 bp to -643 bp region of ME gene. DNA-protein 
complexes were size fractionated in nondenaturing polyacrylamide gels and 
were detected by autoradiography. The arrows on the arrows on the right 
indicate the positions of the shifted complexes. +: present, -: absent, O: 
obese, L: lean, S: sham, A: adrenalectomy, D: dexam ethasone.
+ + + + + + + + ’#■ + + + + + +
- 0 L 0 L O L 0 L S s A A D D
- - - .4 .4 2 2 8 8
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The effects of adrenalectomy of the rats on the binding of the nuclear 
proteins to this 70 bp DNA fragment were also explored. Although there is no 
GRE site in this region, the formation of the Complexes 1-3 were still 
inhibited by adrenalectomy of both obese and lean Zucker rats (lanes 12-13 
in Figure 19). This treatment had an opposite effect on the formation of 
Complexes 4-5. Higher amounts of Complexes 1-3 were formed with 
extracts from obese animals than from lean animals, while the formation of 
Complexes 5-7 were more prominent in lean animals than in obese animals.
When hepatic nuclear proteins from dexam ethasone replaced obese 
and lean Zucker rats were incubated with the 70 bp DNA fragment, the 
intensities of Complexes 1-3 were dramatically increased and the formation 
of complexes 5-7 was greatly reduced compared with those in 
adrenalectomized rats. Again, the levels of Complexes 1-3 were higher in 
obese animals than in lean animals and the levels of Complexes 5-7 were 
higher in lean animals than in obese animals.
When the 152 bp DNA fragment (-642 to -491) was used as the target 
DNA in band shift assays, up to five bands showed up and there were more 
nuclear proteins from obese Zucker rats that bound to the 152 bp DNA than 
from lean Zucker rats (lanes 2-3 in Figure 20). As increasing amounts of 
CIAP were added in the binding reactions, Complexes 1-2 gradually 
disappeared and the formation of Complexes 3-5 were increased (lanes 4-9 
in Figure 20). When the sam e amounts of CIAP were added, the formation of 
Complexes 3-5 were found to be formed in larger amounts in lean animals 
than in obese  animals.
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Figure 20. Effect of dephosphorylation on band shift pattern with the 152 bp 
fragment. Hepatic nuclear extracts prepared from obese and lean Zucker 
rats that had been treated with specified amount of CIAP were incubated 
with 32P-labeled DNA fragments containing the -642 bp to -491 bp region of 
ME gene. DNA-protein complexes were size fractionated in nondenaturing 
polyacrylamide gels and were detected by autoradiography. The arrows on 
the right indicate the positions of the shifted complexes. +: present, -: absent, 
O: obese, L: lean.
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BuGR2 reduced the binding of hepatic nuclear proteins to the 222 bp 
fragment
Since the glucocorticoid status in obese and lean Zucker rats showed 
a dramatic influence on the binding of the hepatic nuclear proteins to the 222 
bp DNA fragment, which contains a  GRE, it w as of value to investigate 
whether the glucocorticoid receptor exists in the DNA-protein complexes 
formed in the band shift assays. In one of the band shift assays, we treated 
the hepatic nuclear extracts from obese Zucker rats with 10 units of BuGR2 
before the binding reaction took place (lane 3 in Figure 21). Generally the 
binding of hepatic nuclear proteins to this 222 bp DNA fragment was 
considerably reduced by the inclusion of the BuGR2 in the binding reaction. 
This decrease  in binding can be observed in the formation of all the DNA- 
protein complexes. Interestingly, a  very faint band showed up at the position 
slightly below the well. This relatively faint band could not be caused  by the 
binding of the BuGR2 antibody to the labeled 222 bp DNA fragment because 
incubation of BuGR2 with only the labeled probe showed no shifted band 
(data not shown).
Lanes 4-6 in Figure 21 shows the effect of different amount of BuGR2 
on the formation of the DNA-protein complexes. As the amount of BuGR2 
included in the binding reactions was increased (0.1, 1 ,2  units), the 
formation of the DNA-protein complexes decreased except the band just 
below the well, which might be a super-shifted band.
Therefore, it seem s that the glucocorticoid receptor antibody has an 
inhibitory effect on the binding of the hepatic nuclear proteins from obese 
Zucker rats to the 222 bp DNA fragment.
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Nuclear Extract - 0 o 0 O O
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Figure 21. Effect of GR antibody on band shift assay  with the 222 bp 
fragment. Hepatic nuclear extracts prepared from obese Zucker rats were 
incubated with 32P-labeled DNA fragments containing the -712 bp to -491 bp 
region of ME gene, together with specified amount of monoclonal antibodies 
(BuGR2) against GR. DNA-protein complexes were size fractionated in 
nondenaturing polyacrylamide gels and were detected by autoradiography. 
The arrows on the right indicate the positions of the shifted complexes. +: 
present, absent, O: obese, L: lean.
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Effects of the anti>HNF3a antiserum on the binding of hepatic nuclear 
proteins to the 222 bp DNA fragment
Since the 222 bp DNA fragment also contains an HNF3 binding site 
and the binding of the hepatic nuclear proteins from obese and lean Zucker 
rats were significantly affected by the phosphorylation status of the nuclear 
proteins, we looked into the effect of the treatment of the hepatic nuclear 
proteins with the anti-HNF3a antiserum on the formation of the DNA-protein 
complexes (Figure 22).
Surprisingly, when the anti-HNF3a antiserum w as included in the 
binding reactions, two extra bands (Complexes a, b) were seen  (lanes 4-5 in 
Figure 22) compared with the band shift assays carried out with only the 
labeled probe and the hepatic nuclear proteins from obese (lane 2 in Figure 
22) and lean (lane 3 in Figure 22) Zucker rats. There w as more Complex a 
formed by obese nuclear extract then by lean nuclear extract. In contrast, 
there w as more of Complex b formed by lean nuclear extract than by obese 
nuclear extract.
The formation of the four DNA-protein complexes by the binding of 
nuclear proteins not treated with the anti-HNF3a antiserum were still 
observed when the band shift assays were performed with the inclusion of 
the antiserum. The patterns and intensities of three of these  bands 
(Complexes 1, 2, and 4) were not significantly affected when the nuclear 
proteins were treated with the antiserum.
The most significant change caused by the treatm ent with the anti- 
HNF3a antiserum was the dramatic increase of the intensity of Complex 3. 
However, there w as still more Complex 3 formed by the obese nuclear
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Figure 22. Effect of HNF3 Ab on band shift pattern with the 222 bp fragment. 
Hepatic nuclear extracts prepared from obese and lean Zucker rats were 
incubated with 32P-labeled DNA fragments containing the -712 bp to -491 bp 
region of ME gene, together with or without polyclonal antiserum against 
HNF3a. DNA-protein complexes were size fractionated in nondenaturing 
polyacrylamide gels and were detected by autoradiography. The arrows on 
the right indicate the positions of the shifted complexes. +: present, absent, 
O: obese, L: lean.
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extracts (lane 4 in Figure 22) than that formed by the lean nuclear extracts 
(lane 5 in Figure 22).
It seem s that the anti-HNF3a antiserum increased the binding of the 
hepatic nuclear proteins from obese and lean Zucker rats to the 222 bp DNA 
fragment because there was much less free labeled probe left when the 
antiserum w as used in the binding reaction.
SDS PAGE analysis of proteins in DNA-protein complexes from band 
shift assays
In order to analyze the proteins present in the Complex 1 in Figure 11, 
15 fold scale-up band shift assays were performed with the 222 bp DNA 
fragment a s  labeled probe. Two control reactions were run without any target 
DNA. After exposure to the X-ray films, the original gels were aligned with 
the X-ray films and the gel slices at the sam e position as Complex 1 were 
excised. The proteins in the excised gel slices were eluted and subjected to 
4-20% SDS-PAGE analysis. As shown in Figure 23, there were at least 3 
proteins in Complex 1 formed by the binding of hepatic nuclear proteins to 
the 222 bp DNA fragment (lanes 2 and 4). The sizes of the proteins were 
approximately 123 kd, 67 kd, and 31 kd. There were larger amount of 
proteins in Complex 1 from obese animal (lane 2) than that from lean animal 
(lane 4). The protein complex in the unbound nuclear extracts which has the 
sam e migration rate as the DNA-protein Complex 1 seem s to contain more 
proteins of smaller sizes than Complex 1 (lanes 1 and 3 in Figure 23). A 
protein with a M.W. of approximately 33 kd was present in the unbound lean 
protein complex and absent from the unbound obese protein complex.
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Figure 23. SDS PAGE of Complex 1. The DNA-protein complex 1 indicated 
in Figure 11 were isolated from a 15 fold scale-up reaction and subjected to 
SDS-PAGE analysis. The protein complexes from the sam e position in the 
band shift assays perfomed without adding any DNA were also obtained and 
analyzed. Lane 1, obese nuclear proteins at the sam e position of Complex 1. 
Lane 2, obese  Complex 1. Lane 3, lean nuclear proteins at the sam e 
position of Complex 1. Lane 4, lean Complex 1. Lane 5, protein marker. The 
protein bands refered in the text were indicated by the arrows.
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Analysis of the hepatic nuclear proteins using polyacrylamide gel 
electrophoresis
Identification of the proteins that are apparently present at higher or 
lower levels in, or even absent from, the obese rat hepatic nuclei and 
information of their function and regulation may provide insight into the 
abnormal responsiveness of certain genes to glucocorticoid in the obese rat.
SDS PAGE
SDS PAGE of the hepatic nuclear proteins from obese and lean 
Zucker rats showed a large number of bands with a  wide range of molecular 
sizes (Figure 24). No obvious differences were observed in the gel patterns 
of the obese (lane 2) and lean (lane 3) hepatic nuclear extracts. They both 
have the sam e number of bands with approximately identical intensities. 
2=D.PA<3E
Since no obvious differences were detected between the nuclear 
protein profiles of obese and lean Zucker rats using SDS-PAGE, the nuclear 
proteins were subjected.to 2-D PAGE, which has a  much higher resolving 
power in detecting individual proteins or polypeptides.
2-D PAGE analysis of the hepatic nuclear extracts from obese and 
lean Zucker rats showed that the overall composition of nuclear protein 
profiles were generally similar (Figure 25) except that there were two extra 
spots in lean nuclear extract which were absent from the obese nuclear 
extract (Figure 25-26). They have the sam e pi which is 5.2. Their M.W. were 
approximately 31 kd and 32 kd, respectively. Attempting to characterize 
these  proteins, the protein spots which had been transfered from the gels to 
the PVDF mem branes were isolated for sequencing analysis. Unfortunately,
Figure 24. SDS PAGE of nuclear proteins from obese and lean Zucker Rats. 
Hepatic nuclear extracts prepared from obese and lean Zucker rats were 
analyzed using an 8% SDS-PAGE. Lane 1, lean nuclear extract. Lane 2, 
obese  nuclear extract. Lane 3, protein marker.
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Figure 25. 2-D PAGE of hepatic nuclear proteins from lean and obese 
Zucker rats. A, lean nuclear extract; B, obese nuclear extract. The 2-D PAGE 
w ere performed a s  described in the Materials and Methods. The two spots 
(31 and 32 kd respectively) in lean nuclear extract are pointed by the left 
arrows. The right arrows indicate the position of the internal marker 
tropomyosin.
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Figure 26. A close up look at the 2-D PAGE of hepatic nuclear proteins from 
lean and obese Zucker rats. Legends are the sam e a s  in Figure 25.
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the N-terminals of these two proteins were blocked and the sequences of 
them could not be obtained.
DISCUSSION
Our initial band shift assays performed with five DNA fragments which 
cover the entire 882-bp upstream region of the ME gene showed that 
generally larger amounts of specific DNA-protein complexes were formed 
when hepatic nuclear proteins from obese rats were used in comparison to 
hepatic nuclear proteins from lean rats (Figures 9-10, 12-14).
Bray and York (118) have previously shown that the hepatic and 
adipose mRNA levels for ME and GAPDH were increased in young obese 
falfa rats. Our results from the band shift assays indicated alteration in 
binding of proteins to the upstream region of ME gene. These may contribute 
to the increase of ME transcription shown by Jensen  et al. (261).
The upstream region of the rat ME gene has many known binding 
sites (Figure 1) for transcription factors, many of which have been well 
studied (Table 2). These protein binding sites have been found to exist in 
many eukaryotic genes that are under the control of multiple hormones
(262).
The binding of hepatic nuclear proteins to the 134 bp fragment
Up to seven DNA-protein complexes were detected in the band shift 
a ssay  using the 134 bp DNA fragment as target DNA and hepatic nuclear 
extracts from obese  and lean Zucker rats as proteins (Figure 9). This is not 
surprising because  the DNA sequences in the 134 bp fragment used in band 
shift assays is located around the cap site (-102 to +33) and have been 
shown to be bound by many hepatic nuclear proteins (249). The function of 
this region seem s to account for the basal expression of the ME gene, which
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has been suggested to be one of the constitutive or "house keeping" genes
(263).
Morioka et al. have found a 10-bp direct repeat of the sequence 5'- 
CTCGCCACCC-3' between -73 and -51, separated by 3 bp. Using DNase I 
footprint analysis Petty et al. have been able to demonstrate that each copy 
of the repeated sequence was bound by a separate  se t of proteins (249). 
Deletion mutation experiments and transcription competition analysis also 
showed that this direct repeat is important to maintain the basal 
transcriptional activity of the ME gene (249). Although the function of this 
rarely seen  direct repeat is still not clearly understood, it has been shown to 
be bound by rat hepatic nuclear proteins in a  thyroidal status dependent 
m anner (249). It is possible that the nuclear proteins which bind to this direct 
repeat are  required for the assembly of the specific transcription initiation 
complex for the ME gene.
Three of the nine CCGCCC hexanucleotide boxes possessed  by the 
ME gene, which have been speculated to be involved in the chromatin 
assem bly required for gene expression, were also found to be in this 134 
sequence (245). Moreover, it has been reported that the sequences between 
-29 and +28 in this region were protected from DNase I in the footprinting 
experiment and were essential for the basal transcription activity, indicating 
that it might be bound by the transcription initiation complex or som e of its 
components.
Therefore the seven bands observed in the band shift assay  
performed with the 134 bp DNA fragment might represent DNA-protein 
complexes formed by several different transcription factors or by different
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combinations of several transcription factors involved in the transcription 
initiation.
Band shift assays performed by other researchers showed that most 
of the sequences in the 134 bp region were similarly bound by hepatic 
nuclear proteins from hypothyroid, euthyroid, and hyperthyroid rats, except 
the direct repeat to which the binding of rat hepatic nuclear proteins was 
dependent on the thyroidal status of the rats (249). Although the obese 
Zucker rats are generally considered to be in a  mild hypothyroid state (69), 
we did not observe any significant differences between the levels at which 
the 134 bp DNA fragment was bound by the hepatic nuclear proteins from 
obese  and lean Zucker rats. This may result from the interaction between the 
nuclear proteins that bind to the direct repeat and those that are positively 
regulated by glucocorticoids or insulin since obese Zucker rats, as  has been 
mentioned above, are  hyperresponsive to the effect of glucocorticoids and 
have a higher level of hepatic ME mRNA compared with lean Zucker rats 
(118). It has also been shown that insulin increases the rat hepatic mRNA 
levels even in the absence  of thyroid hormone, w hereas the thyroid hormone 
w as not able to increase the hepatic mRNA levels in the absence  or low 
levels of insulin (230).
Although the sequences from +1 to -41 have been shown to be 
sufficient to initiate expression of the ME gene, the region +1 to -102 is not 
enough for maximal promoter activity (245). Sequences further upstream are 
involved in transcriptional regulation of the ME gene by a  number of nuclear 
proteins.
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The binding of hepatic nuclear proteins to the 385 bp fragment
The band shift assay  performed with the 385 bp DNA fragment 
yielded four distinct bands (Figure 10).
Located at -103 to -488, the 385 bp DNA fragment contains a number 
of binding sites for transcription factors and nuclear proteins known to be 
important in the regulation of transcription activity of a variety of genes 
(Figure 1, Table 2).
AP-1 binding site
The AP-1 (activator protein-1), initially described as a  DNA-binding 
protein in Hela cell extracts (264), has been shown to be bound by Jun-Jun 
or Jun-Fos dimers (265). Studies performed by Diamond et al. (266) have 
dem onstrated that the changes in the ratio of Fos to Jun proteins in the AP1 
complex could shift the glucocorticoid regulation of the m ouse proliferin gene 
from positive to negative. It has also been shown by other researchers (267) 
that different cell-specific environments could result in different interactions 
of the GR with the Jun and Fos proteins, which in turn could manifest 
different functions.
c-Jun has been shown to possess a  glutamine-rich activation domain 
that could interact with other DNA binding proteins such as the sterol 
response element binding protein (268). Coincidently Sp1, a s will be 
discussed below, also contains a glutamine-rich region in its amino-terminal 
domain which might be involved in the interaction with other transcription 
factors (269).
Sp1 and IRE-II
As a result of enhanced parasympathetic drive to the pancreatic p 
cells, insulin secretion is dramatically increased in the obese faffa rat (46,
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106, 270-271). The resulting high insulin level in obese  rats might directly 
increase the binding of certain nuclear proteins to the IREs in many gene 
promoters. IRE-II in the 385 bp DNA fragment is a  positive insulin response 
elem ent similar to the GAPDH gene promoter IRE-A (224) as has been 
shown by Garcia-Jimenez et al. (230) It overlaps the Sp1 elem ent in the 
sam e region (Figure 1, Table 2). It has been suggested that insulin might 
enhance the expression of ME gene by interacting with the Sp1 protein and 
subsequently inducing the binding of the 95 kd and 105 kd Sp1 species 
(230).
Sp1 is a  transcription factor with the unusual property of activating 
TATA-less promoters (272). The gene for Sp1 w as cloned in 1987 (273), a 
year after it was purified to homogeneity and biochemically characterized 
(274). The Sp1 element which it recognizes (Table 2) exists singly or multiply 
in a  vast array of cellular and viral promoters (269), including the ME gene 
promoter used in this study. Sp1 possesses a glutamine-rich region in its 
amino-terminal domain which may interact with other transcription factors.
In a  reconstitution study performed in 1990 (272), Pugh and Tjian 
provided evidence for the existence of "coactivators" which are required for 
Sp1 activation of transcription. Moreover, by comparing the TFIID 
requirement at TATA containing promoters and TATA-less promoters, they 
were able to demonstrate the presence of an additional "tethering" activity 
distinct from the above mentioned coactivators. They proposed that the 
tethering activity might interact with both Sp1 and other transcription factors 
such a s  the TATA binding protein and assist the formation of the basal 
transcription initiation complex at the TATA-less promoters (272).
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Although a sequence similar to TATA box has been found at -621 to - 
626 of the ME gene, whether it really functions as a  TATA box is 
questionable because a TATA box with a  position this far from the 
transcription start site is very rare. Thus it seem s more appropriate to classify 
the ME gene promoter a s  a TATA-less promoter.
Therefore it is very likely that Sp1 and/or the IRE-II binding proteins 
224) might participate in the formation of one or more of the four DNA- 
protein complexes detected in the band shift assay  performed with the 385 
bp DNA fragment (Figure 10).
As will be discussed below, binding of hepatic nuclear proteins from 
obese  and lean rats to a 222 bp DNA, which locates just upstream of the 385 
bp region, requires proper phosphorylation of the nuclear proteins.
Sp1 has also been shown to have the ability to cooperate with the sterol 
regulatory element-binding protein in sterol regulation of certain genes such 
a s  the low density lipoprotein receptor gene (269).
TRE
The regulation of ME gene expression by thyroid hormones has been 
extensively studied by V. M. Nikodem's group, the sam e group which 
conducted molecular cloning and structure characterization of the ME gene 
(235, 245, 249, 268).
It has been demonstrated that the thyroid hormone increases the level 
of ME mRNA in rat livers by both transcriptional activation and stabilization of 
malic enzym e mRNA precursor (275). Concomitantly, a  TRE in the ME gene 
w as identified (248) and functionally characterized (276).
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The binding to the AP-1 site on the 385 bp DNA fragment by hepatic 
nuclear proteins from euthyroid rats was higher compared to the hypothyroid 
rats and much lower if compared to the hyperthyroid rats. As has been 
mentioned above, the thyroidal status has a  similar effect on the binding to 
the unique direct repeat on the 134 bp DNA fragment by the rat hepatic 
nuclear proteins (249). This indicates that the thyroid hormone receptors, 
which are the cellular analogues of the viral erbA oncogene (277), might 
somehow interact with c-Jun protein and the nuclear proteins that bind to the 
10 bp direct repeat in the 134 bp fragment. The fact that these  three 
elem ents lie close to each other supports this view (Figure 1). Moreover, the 
thyroid hormone receptor has also been shown to interact with components 
of the transcription initiation machinery such a s  TFIIB (278) and TATA 
binding protein (279).
Therefore the four bands shown in lanes 2 and 3 in Figure 10 might 
represent the DNA-protein complexes formed through the binding to the cis- 
acting elem ents by the above mentioned transcription factors or nuclear 
proteins. W hether the DNA-protein complexes are formed by one or more 
proteins is not clear.
An obvious difference between the 134 bp and 385 bp DNA 
fragments is that the latter was bound by the hepatic nuclear proteins from 
obese rats in a greater extent than by those from lean rats (Figure 10), while 
there w as no significant difference in the binding to the other. This might 
result from increased binding of insulin related factors to the IRE-!I/Sp1 site 
in obese Zucker rats. Other nuclear proteins which positively regulate ME
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gene expression might also participate in the formation of these specific 
DNA-protein complexes.
The binding of hepatic nuclear proteins to the 222 bp fragment
A distinctive feature of the 222 bp DNA fragment is that the patterns in 
which the hepatic nuclear proteins bind to it are different between obese  and 
lean Zucker rats (Figure 11). This difference could result from differential 
binding to the 222 bp DNA fragment by a single transcription factor or a 
combination of interactions among many transcription factors that bind to this 
or even other regions of the ME gene promoter.
GRE
The 3' end of the 222 bp DNA fragment contains an imperfect GRE 
(Figure 1, Table 2). W hether this GRE in the ME gene is really bound by 
glucocorticoid receptor has not been confirmed by experiments. Being a 
partially palindromic sequence, the GRE can be bound by either monomers 
or dimers of the glucocorticoid receptor (173-175). The binding to the GRE 
by the receptor dimers is cooperative (173-175). As has been mentioned in 
the Review of Literature, the glucocorticoid receptor binds to the GRE with its 
"zinc fingers" which are located in the DNA binding domain of the GR 
protein. Many nuclear proteins have been found to have a synergistic effect 
on the transcriptional activity of the GR. It's suggested that they may serve to 
"bridge" receptors to the transcription machinery (262). Therefore the GR 
may participate, through interaction with other nuclear proteins, in the 
formation of one or more specific DNA-protein complexes observed in the 
band shift assay  performed with the 222 bp DNA fragment.
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TATA
The TATA box in the 222 bp DNA fragment does not seem  to really 
function in the initiation complex of transcription since its position is too far 
from the traditional TATA box, which is always located close to the 
transcription start site. But the possibility that it might somehow be involved 
in transcription can not be ruled out because no experiments have been 
performed to investigate its function.
HNF3 and IRE-I
In contrast to the positive IRE-II at -162 to -169 in the 385 bp DNA 
fragment, the IRE-I at -693 to -687 in the 222 bp DNA fragment resem bles 
the PEPCK promoter IRE (230), the binding to which by a hepatic nuclear 
protein has been shown to be negatively regulated by insulin (230). Unlike 
the PEPCK IRE, which overlaps the AF2 element of a composite GRE unit 
(230), the IRE-I in the 222 bp DNA fragment is separated from the GRE 
(Figure 1, Table 2). However, it overlaps a  potential binding site for HNF3 
proteins (Figure 1, Table 2).
The HNF3 family of proteins were originally identified a s  transcription 
factors that bind to promoters and enhancers of several liver specific genes 
and coordinated regulated their expression (280). Later these  proteins were 
found to play important roles in embryogenesis when body axis formation 
and commitment to different developmental fates are decided (281). The 
HNF3 family consists of three proteins (a, p, and y) which share strong 
homology in DNA binding domains that bind to the sam e DNA sequence. 
There are three more regions that are homologous among them, one in the 
amino terminus and two in the carboxyl terminus (282). Moreover, HNF3
101
proteins were also demonstrated to be homologous with the Drosophila 
homeotic gene fork head (282). A possible reason for the existence of three 
related but different HNF3 proteins is that they could be differentially 
modified in response to various signals (280). Thus one possible explanation 
for the observation that the patterns in which hepatic nuclear proteins bind to 
the 222 bp region are different between obese and lean rats is that the ratios 
of different HNF3 proteins binding to this region are different between them.
The overlapping of the IRE-I and HNF3 binding site at the 222 region 
might indicate that the binding by one nuclear protein interferes with that of 
the other. It is possible that one or more DNA-protein complexes detected in 
Figure 11 might result from the retro-excluding binding by the HNF3 proteins 
and IRE-1 binding proteins.
The binding of hepatic nuclear proteins to the 186 bp fragment
Located at -696 to -882, far from the transcription start site, the 186 
bp DNA fragment contains no binding sites for known transcription factors or 
nuclear proteins (Figure 1). However, our results clearly indicated that this 
region of the ME gene is bound by certain nuclear proteins since at least two 
specific DNA-proteins complexes were formed when the 186 bp DNA 
fragment w as incubated with the hepatic nuclear proteins from obese and 
lean Zucker rats (Figure 12).
The levels of binding by the nuclear proteins from obese and lean 
Zucker rats to the 186 bp DNA fragment are different. However the overall 
patterns of the binding are the sam e between obese  and lean animals. 
Therefore this region of the ME enzyme gene might participate in the
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regulation of the expression of the ME gene, but it does not seem  to function 
a s  a  primary factor in the pathway of the regulation.
Like other DNA fragments from the 882 bp upstream region of ME 
gene, the 186 bp DNA fragment was bound at a much higher level by obese 
hepatic nuclear proteins than by lean ones (Figure 12). This might be a 
result of interactions among the nuclear proteins that bind the -696 to -882 
region and those that bind other regions such as HNF3 binding site, IRE-I 
and the GRE which are all located relatively nearby (Figure 1).
The binding of hepatic nuclear proteins to the 49 bp fragment
The binding to the 49 bp DNA fragment (-463 to -511), which contains 
a complete GRE, resulted a major specific DNA-protein complex which is 
more prominent in obese than in lean rats. Because GRE is the only known 
c/s-acting element in the 49 bp region (Table 2), it is very likely that this 
DNA-protein complex is formed by the binding of GR to the GRE. The higher 
level of the complex in obese Zucker rats might indicate that obese  hepatic 
nuclear extract contains more GR. This agrees with the report that W estern 
blotting of nuclear protein extract has shown an increase in GR protein in 
nuclei of obese Zucker rats (261). If this is the case, GR might contribute to 
the formation of the Complex 1 in Figure 11, which resulted from binding of 
hepatic nuclear proteins to the 222 bp DNA fragment since that complex is 
also more prominent in obese rats than in lean rats.
The effect of adrenalectomy
The function of glucocorticoids in the development of obesity in this 
genetic model of obesity has been investigated in a number of ways in the 
past few years (46, 90, 106, 115-116, 130). The results of Bray and York
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(118) identified an increase in the mRNA levels of the genes for ME and 
GAPDH in liver and adipose tissue of obese Zucker rats that w as dependent 
upon glucocorticoids. These increases were eliminated by adrenalectomizing 
the animals and then restored by replacement doses of glucocorticoids. This 
led to their initial hypothesis that the fa gene mutation may result directly or 
indirectly in a change in the levels or activity of one or more transcription 
factors that modulate glucocorticoid regulated genes. Such an effect is likely 
to be expressed in many tissues. While the majority of studies have 
concentrated on glucocorticoid responses in liver and adipose tissue of 
obese rats, evidence that there are also alterations in the central responses 
to the glucocorticoids has been presented from several laboratories (283- 
284).
The finding that the obese nuclei contain more protein that binds to 
DNA in the -712 to -491 region of ME gene, which contains an HNF3 binding 
site, the IRE-I, and an imperfect GRE, and the abolishment of the formation 
of the DNA-protein complex by adrenalectomy of the Zucker rats (Figure 15), 
supports the possibility that there may be alterations in transcription factors 
that modulate glucocorticoid responses in the obese falfa rat.
Cross-talk between signal transduction pathways has been 
recognized a s  a common paradigm in cellular development and 
hom eostasis. Insulin degrading enzyme (IDE) was reported to interact with 
GR and AR (androgen receptor), which may potential couple insulin and 
steroid hormone signaling pathways. This relationship may be important for 
various biological phenomena, such a s  insulin resistance, and specificity of 
steroid hormone action (285).
104
Phosphorylation status
A rapidly growing area of interest in the study of protein 
phosphorylation is the regulation of cellular growth through phosphorylation 
of key nuclear proteins (286). These nuclear proteins include som e 
transcription factors such as CREB (287), Jun, Fos (58, 288-289), NF-kB 
(289), Myc (289), and Myb (290-291), and tumor suppressor proteins such 
a s  pRB (292) and p53 (293-294). Regulation of the activities of these  
proteins can occur through phosphorylation and dephosphorylation 
m echanism s that in turn respond to the timing mechanism of the cell cycle, 
or directly to extracellular signals transduced to the nucleus by "cascade 
events". In addition, som e viral proteins that stimulate cellular growth are 
also regulated by phosphorylation or are able to influence the 
phosphorylation of proteins central to growth regulation (285).
All mem bers of the steroid hormone receptor family are 
phosphoproteins. On incubation of cells or tissues in culture with the 
respective ligands, steroid receptors become hyperphosphorylated. This 
extraphosphorylation is a  rapid process (<30 min) and is associated with 
receptor transformation (295-297). But whether the increase in steroid 
receptor phosphorylation upon hormone treatm ent is the consequence of a 
conformational change, making the receptor a  better substrate for a 
kinase(s) or a  poorer substrate for a phosphatase(s), is unknown (181).
Our study showed that certain DNA-protein complexes formed by 
binding of the 222 bp DNA fragment by Zucker rat hepatic nuclear proteins 
were abolished by dephosphorylation of the nuclear proteins (Figure 16). 
This clearly indicates the involvement of protein phosphorylation in the 
modification of the transcription regulation of the ME gene. When the
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formation of Complexes 1-3 in Figure 16 were abolished by the 
dephosphorylation of the nuclear proteins, the formation of Complex 4, was 
promoted. In fact, a t least two more DNA-protein complexes appeared with 
similar migration rates to Complex 4. It is likely that the nuclear proteins in 
these  small complexes represent those which together, when properly 
phosphorylated, form the Complexes 1-3 which migrates much more slowly. 
T hese proteins can still bind to the DNA but they can no longer interact with 
each other to form a complicated complex on the DNA fragment.
Recent studies indicate that cellular kinases play a prominent role in 
the regulation of members of the steroid/thyroid hormone receptor 
superfamily. PKC (298) and PKA (299) have been implicated to enhance the 
transcription activation activities of the GR (298). PKA was also reported to 
increase the receptor mRNA (300).
Transcriptional regulation by cAMP occurs through a multistep 
process involving activation of cAMP-dependent PKA and subsequent 
phosphorylation of transcription factors such as cAMP response element 
biding protein (CREB) or activating transcription factor-1 which activate 
transcription by binding to the cAMP response elements (CREs) of target 
gene  (301-302). Several genes are  coordinated regulated by both 
glucocorticoids and cAMP (303-306). Moreover, Rangarajan et al. were able 
to dem onstrate that PKA modulates the steroid sensitivity of a target cell by 
enhancing the DNA binding activity of GR for GRE (299).
The activity of adenylate cyclase is under control of both stimulatory 
and inhibitory hormone receptors. Receptors for stimulatory hormones are 
coupled to adenylate cyclase via the stimulatory guanine-nucleotide-binding
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protein Gs while the effects of inhibitory receptors are mediated via one or 
more of the inhibitory G proteins: Gi-1, Gi-2 or Gi-3 (161, 307). A loss of Gi 
function in hepatocyte mem branes in obese Zucker rats but not their lean 
counter parts has been reported (308-309). Houslay showed that ligands 
which enhanced Gja-2 phosphorylation in intact hepatocytes from lean 
Zucker rats failed to do so in hepatocytes from obese animals. They 
suggested that this defect in guanine-nucleotide-mediated "G| function” seen  
in obese  Zucker rats may be due to an inactivating phosphorylation of aG r 2 
caused by elevated PKC activity (161).
However, in our experiments, treatment of Zucker hepatic nuclear 
proteins with PKA failed to enhance the binding of the nuclear proteins to the 
222 bp DNA fragment (Figure 17). PKC treatment of the Zucker hepatic 
nuclear proteins did not increase the binding of the hepatic nuclear proteins 
to the 222 bp DNA fragment either (Figure 18). In fact it decreased the DNA- 
protein complex formation. This is not surprising because the in vivo 
phosphorylation of the nuclear proteins is a well regulated, protein specific, 
amino acid residue specific, and protein kinase specific process. Therefore 
the phosphorylation of the improper nuclear proteins, the phosphorylation of 
the right nuclear protein at the improper residues, or over-phosphorylation of 
the nuclear proteins would decrease the ability of the nuclear proteins to bind 
to specific DNA sites (310).
Nevertheless, DNA-dependent phosphorylation has been suggested 
to be a mechanism for transcription activation (311). it has been shown that 
Sp1 can be quantitatively and efficiently dephosphorylated by protein 
phosphatases, the activities of which do not require the binding of Sp1 to
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DNA and can be inhibited by okadaic acid (312). Thus it is possible that the 
dephosphorylation of Sp1 might account partly for the disruption of som e of 
the DNA-protein complexes formed by the binding of the hepatic nuclear 
proteins to the 222 bp DNA fragment.
Different regions of the 222 bp DNA fragment
In diabetic rats (type I), ME mRNA was undetectable but was 
increased by insulin. The transcription rate of the gene was also reduced in 
the diabetic liver and recovered after insulin therapy (230). Garcia-Jimenez, 
et al. found that the protein/IRE-l complex increased in liver nuclear extracts 
from diabetic rats and decreased after insulin administration, suggesting that 
this sequence could mediate negative regulation by insulin a s  has been 
reported by O'Brien (3, 225). In contrast, the protein/IRE-l I complex 
decreased in liver nuclear extracts from diabetic rats and increased after 
insulin administration.
In our study the Complex 1 formed by the 222 bp DNA fragment and 
nuclear proteins increased in obese Zucker rats compared to those from the 
lean Zucker rats. In order to find out if IRE-I is involved in this increase we 
used a 70 bp fragment, which contain the overlapping IRE-I and HNF3 
binding site, in the band shift assay  and the result showed that the binding of 
nuclear proteins to this region was weak in both obese and lean Zucker rats 
(Figure 19). This agrees with Garcia-Jimenez’s report because the insulin 
level is not reduced in either the lean or obese Zucker rats. However 
glucocorticoid replacement on adrenalectomized obese and lean Zucker rats 
dem onstrated a  dramatic increase in binding of nuclear proteins to the 70 bp 
region (Figure 19). We suspect the increase in binding was caused by HNF3
108
other than the IRE-I binding protein because the replacement with 
dexam ethasone increased the hepatic ME mRNA level in Zucker rats (118); 
and proteins of the HNF3 family, the binding sites of which were found to 
overlap IRE, have been shown to be required for the full induction of PEPCK 
gene transcription by glucocorticoids (246). Moreover, the HNF-3p protein 
has been shown to possess two casein kinase I and two casein kinase II 
phosphorylation sites (313), indicating a putative regulatory role 
phosphorylation might play,
However the possibility cannot be ruled out that insulin might indirectly 
regulate the glucocorticoid responsiveness of genes through modulation of 
transcription factor gene expression, which has been shown to be true for 
the expression of c-fos (273).
The GRE and IRE/HNF3 binding sites are located fairly close to each 
other in the upstream region of ME gene. Our finding that the IRE/HNF3 
binding site needs the presence of GRE or treatment of the rats with 
glucocorticoids to form the specific DNA-protein complex intrigue us. We 
propose that part of the metabolic changes in fa/fa rats might be caused  by 
the improper phosphorylation of one or more nuclear proteins which interact 
with GR, HNF, and/or insulin related factors to regulate gene expressions.
The 152 bp DNA fragment derived from the 222 bp region generated 
a t least 5 DNA-protein complexes when bound by hepatic nuclear proteins 
from obese and lean Zucker rats (Figure 20). The formation of Complex 1 by 
obese rat nuclear extract was much stronger than that by lean nuclear 
extract. This may due to the presence of the GRE in this region since the
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position of this complex is comparable to the position of Complex 1 in Figure
11.
Complexes 1 and 2 in Figure 20 were abolished by the 
dephosphorylation of the nuclear proteins indicating that the formation of 
these  two complexes require the phosphorylation of the involving proteins. 
Dephosphorylation of the nuclear proteins seem s to inhibit the interactions 
among DNA binding proteins giving rise to many smaller DNA-protein 
complexes that contains fewer nuclear proteins or single protein (i.e. 
Complexes 3-5).
Bu£B2
Our study showed that formation of specific DNA-proteins complexes 
were decreased by the BuGR2 antibody (Figure 21), which is directed 
against the rat glucocorticoid receptor, indicating that this antibody blocks 
the binding of glucocorticoid receptor to its cognate sequence and/or the 
interaction of the GR with other transcription factors. This finding further 
supports the GR's role in the regulation of the expression of ME gene.
It is not surprising that the BuGR2 antibody blocked the formation of 
the  DNA-protein complex instead of binding to the DNA-protein complex and 
causing a supershifted band because the BuGR2 antibody "has been shown 
to react with a single epitope in the DNA-binding domain of the 
glucocorticoid receptor". The binding of the antibody to GR might also 
change the conformation of the protein and affect its transactivation activity, 
which distributes all over the entire GR protein (262).
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Anti-HNF3ot antiserum
In contrast to the inhibitory effect of BuGR2 on the binding to the 222 
bp DNA fragment, the treatment of the Zucker hepatic nuclear proteins with 
anti-HNF3a antiserum actually increased the binding. This increase in 
binding might be mediated by the interaction of HNF3a with its antiserum, 
which might somehow changed the conformation of the HNF3a protein, 
rendering it able to bind to the DNA. This cannot be caused by the binding of 
HNF3a antiserum to the probe since the antiserum alone did not form any 
shifted band when incubated with the labeled 222 bp fragment (Data not 
shown). Future experiments with monoclonal antibodies or antibodies 
against other HNF3 proteins such as HNF3p may resolve this question.
Proteins in Complex 1
When the DNA-protein complex 1 (Figure 11) from a scaled up band 
shift assay  were resolved in SDS PAGE, a protein with a M.W. of 123 kd w as 
seen  in the complexes formed with both obese and lean hepatic nuclear 
extracts (lanes 3 and 5 in Figure 23). A 31 kd protein was present in the 
obese Complex 1 w hereas a sm ear around this M.W. range was seen  in the 
lean Complex 1, probably indicating the presence of several proteins.
An interesting finding is that when the original hepatic nuclear proteins 
were run on the non-denaturing PAGE, protein-protein complexes that have 
the sam e migration rate as Complex 1 were found to contain different 
proteins between obese and lean rats (lanes 2 and 4 in Figure 23). The 
protein-protein complex in obese extract has the sam e components as the 
DNA-protein Complex 1. In contrast there were clearly one extra protein in
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the protein-protein complex in the lean nuclear extract compared to the DNA- 
protein Complex 1. The M.W. of the this protein is 33 kd.
A possible explanation for the absence of this protein from the DNA- 
protein complex 1 might be that this small protein interacts with the larger 
proteins to form protein-protein complexes in the lean nuclear extracts.
When the target DNA w as available, the small protein may dissociate from 
the larger proteins and bind to the target DNA to form small DNA-protein 
complexes such as Complex 4 in Figure 11. The larger proteins also bind to 
the target DNA but the larger protein them selves have a lower concentration 
in lean extracts compared with the obese extracts. The possibility that the 
absence of this 33 kd protein from the obese nuclear extract represent the fa 
defect is very appealing.
SDS PAGE of the original nuclear extracts
The SDS PAGE of the original nuclear extracts from obese and lean 
Zucker rats demonstrated a  similar overall pattern (Figure 24). No extra 
bands were seen  in either the hepatic nuclear extracts or the lean ones. The 
concentration of most of the proteins that can be resolved showed an 
obvious increase in hepatic nuclear extracts from the obese Zucker rats 
compared to those from the lean ones (Figure 24).
2-D PAGE of the original nuclear extracts
Since its introduction in 1975 by O'Farrell e t al. (260), high-resolution 
two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(2D-PAGE) of proteins has been used to examine a wide variety of biological 
system s. It is unmatched by any other technique for simultaneously resolving
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hundreds of polypeptides. The application of this method has been 
documented in thousands of publications (314).
The nucleus, the site of DNA replication and differential gene 
expression, is one of the major subcellular organelles that are  critically 
involved in cellular proliferation and differentiation (315). The nucleus is an 
extremely complex structure containing DNA, RNA, and about 5-15% of the 
total cellular protein according to the particular cell type. In general, nuclear 
proteins include histone proteins which are relatively basic and generally 
associated with DNA, and nonhistone proteins which are highly complex and 
heterogeneous, relatively acidic, and associated with all subnuclear 
components. The functions of nonhistone proteins range from structural, 
enzymatic, to gene regulatory functions. The nonhistone proteins include 
nucleoskeletal proteins (316), RNA splicing and transport proteins, sequence 
specific DNA-binding proteins (317), hormone and growth factor receptor 
molecules (318), oncogene and tumor suppressor proteins (319), protein 
kinases and phosphatases (320), transcriptional activators and repressors 
(321), coactivators, adaptors, and accessory proteins (322).
With the development of high resolution 2-D PAGE many reports have 
appeared describing detailed analysis of nuclear associated polypeptides 
from both normal and transformed cell lines and whole tissue samples. 
Detailed rat liver epithelial cell nuclear protein database has been 
established (315). The 2-D PAGE study of differential polypeptide 
expression in adipose tissue of lean and obese Zucker rats performed by 
Laurent-Winter et al. showed an increase in the accumulation of several 
peptides in the adipose tissue of obese rats at 30 days of age (323).
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However 2-D PAGE information about the nuclear proteins from Zucker rats 
has not been reported before our study.
Although the SDS PAGE of the nuclear extracts showed an increase 
of the concentration of most of the proteins in the obese rats, the result from 
the 2-D PAGE (Figure 25-26) showed two spots in the hepatic nuclear 
extracts from the lean Zucker rats. These two proteins have a pi of 5.4 and 
their M.W. are approximately 31 kd and 32 kd, respectively. The fact that 
they are N-terminal blocked is not surprising because this happens with most 
of the eukaryotic nuclear proteins.
Since the falfa rats are supposed to have a defect in the function of 
the receptor for the ob gene product, it is possible that the absence of the 
two proteins in the falfa nuclear extracts might represent the impairment of 
the receptor for the ob gene product.
Interestingly, the difference between the M.W. of these two proteins 
(31 kd and 32 kd) and that of the small protein in the protein-protein complex 
with the sam e migration rate as the DNA-protein Complex 1's (33 kd) is 
practically ignorable because these  data were obtained from different PAGE 
with different molecular weight standard and measuring errors can easily 
cause such a difference. Thus, the 33 kd protein absent from obese nuclei is 
like the sam e a s  the 31 and 32 kd proteins shown absent from the 2-D 
PAGE. Future investigation needs to be conducted to further characterize 
these  proteins.
SUMMARY
The binding of proteins from hepatic nuclear extracts of lean and 
obese  Zucker rats to the upstream region of the gene for one of the 
glucocorticoid-dependent enzym es has been tested using band shift assays. 
DNA fragments from the upstream region of the malic enzyme gene were 
used as target DNAs. Nuclear extracts were prepared from young lean and 
obese Zucker rats (4-6 weeks old).
An increase in binding of nuclear proteins to the upstream region of 
ME gene w as observed in nuclear extracts from obese rats. The specificity of 
the binding was demonstrated by adding excess amount of either unlabeled 
target DNA or unrelated DNA in the binding reaction.
A 222 bp DNA fragment (-712 to -491) from the upstream region of 
ME gene was found to be bound in different patterns by the hepatic nuclear 
proteins from obese and lean Zucker rats. A large DNA-protein complex w as 
found to be more prominent in obese rats than in lean rats, while other DNA- 
protein complexes were more prominent in lean rats than in obese rats.
Adrenalectomy reduced a specific DNA-protein complex formation 
and glucocorticoid replacement restored the specific DNA-protein complex 
formation in both lean and obese rats.
Alkaline phosphatase treatment of the nuclear proteins reduced the 
specific DNA-protein complex formed with the 222 bp DNA of ME gene in 
both obese and lean rats.
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A monoclonal antibody against glucocorticoid receptor was found to 
interfere with the formation of a large specific DNA-protein complex when the 
222 bp DNA fragment was used.
2-D PAGE of the nuclear proteins from obese and lean rats showed 
that there were two proteins present in lean nuclear extract but absent from 
obese nuclear extract.
CONCLUSION AND PERSPECTIVES
Differences in nuclear proteins binding to the upstream region of ME 
gene between lean and obese Zucker rats may reflect changes in 
phosphorylation state of the nuclear proteins. Glucocorticoid receptor seem s 
to be involved in the regulation of the phosphorylation status of the nuclear 
proteins.
Cloning of the Fa gene will provide invaluable information in the 
obesity study. However, how the product of Fa gene interacts with the signal 
transduction pathways and regulates gene expression needs to be clarified 
before the m echanism s of the development of obesity syndrome can be fully 
understood.
The purification and characterization of the two nuclear proteins in 
lean Zucker rats that are absent from obese Zucker rats may provide insights 
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